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ABSTRACT
ENDOTHELIAL NITRIC OXIDE SYNTHASE AND GROWTH FACTOR 
REGULATION OF FLOW-MEDIATED VASCULAR REMODELING
David Anthony Tulis 
Old Dominion University and Eastern Virginia Medical School
1997
Director Dr. Russell L. Prewitt
This study was designed to characterize structural remodeling of male Wistar rat 
mesenteric arteries exposed to elevated blood flow in vivo for 1, 3, or 7 days. A series of 
arterial ligations induced blood flow increases in ileal and second-order branch arteries 
compared to same animal control vessels. Neither mean carotid nor local mesenteric 
arterial pressures changed significantly pre- to post-ligation. The primary flow-mediated 
force in both vessels was shear stress with possible involvement of acute stretch-induced 
wall stress in the ileal artery. Significant luminal expansion and medial wall hypertrophy 
occurred in the ileal and second-order arteries in a time-dependent fashion. Increases in 
extracellular connective tissue occurred concomitantly with arterial remodeling. Wall 
thickness to lumen diameter ratios did not change in any vessel at any time when 
compared to controls, suggesting normalization o f flow-induced wall stress through 
vascular remodeling.
Immunostaining for proliferating cell nuclear antigen and nuclear profile analyses 
indicate that both medial SMC and intimal EC hyperplasia contribute to flow-induced 
remodeling o f the vessel wall. Immunostaining for eNOS suggests its upregulation in 
response to elevated flow at all time points. Results from in situ hybridization reveal
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significantly elevated PDGF-A mRNA expression in the media after 24 hours and in the 
endothelium after 3 and 7 days. Medial wall and endothelial expression of bFGF and 
TGF-31 were negligible in both control and high flow vessels at all time points. Basal 
levels of PDGF-B transcripts were detected in control and high flow vessels, with no 
significant differences between the two groups. The findings from this study suggest flow- 
stimulated arterial remodeling in vivo involves SMC and EC hyperplasia and increases in 
extracellular connective tissue. This vessel wall restructuring may involve the actions of 
NO and PDGF-A as regulators of flow-stimulated growth; however, bFGF, TGF-fll, and 
PDGF-B do not seem to be involved.
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Regulation of arterial tone, structure, and growth is accomplished through a 
variety of endogenous biochemical and biophysical factors. Vasoactive chemical 
mediators of vascular physiology include eicosanoid products, endothelial-derived relaxing 
and hyperpolarizing factors, mitogenic growth factors, angiogenic growth promoters and 
inhibitors, and autocrine and paracrine cytokines. Biophysical mechanical factors 
regulating vascular physiology include two primary hemodynamic forces: shear stress and 
circumferential wall stress. These various chemical factors and biomechanical forces help 
maintain normal vascular homeostasis as well as influence vascular growth and remodeling 
during angiogenesis, vasculogenesis, apoptosis, and vessel rarefaction. Alterations in 
these parameters, however, have been implicated in the development of vascular 
pathologies such as localization of atherosclerotic foci, pathogenesis o f intimal and 
subintimal neoplasias, development of systemic hypertension, and diabetic microvascular 
disease. In an effort to further understand the contributions o f biophysical mechanical 
forces and biochemical mediators on vascular pathophysiology, this research project 
characterizes the adaptive responses of rat small mesenteric arteries exposed to in vivo 
increases in blood flow under normotensive conditions. The relative contributions of the 
two primary flow-mediated hemodynamic forces in stimulating arterial remodeling will be 
assessed using a unique in vivo experimental model. Complete histologic and cellular 
analyses will be made of the gross morphological alterations induced by these stresses, and 
elucidation of the possible signal transduction and transmission pathways will be made 
through in situ hybridization and immunocytochemical approaches. The results from this
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study will further characterize blood flow-associated stresses and their impact on 
biochemical signaling as endogenous stimuli capable of inducing arterial remodeling under 
in vivo conditions.
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CHAPTER D 
BACKGROUND AND LITERATURE REVIEW
Arterial Anatomy and Physiology
The arterial cross-section is composed of the intima, primarily an EC monolayer, 
the media, the muscular wall of the artery composed o f  SMC surrounded by an internal 
and external elastic laminae, and the adventitia, a dense collagenous structure containing 
bundles of collagen fibrils, elastic fibers, some SMCs and many fibroblasts. The EC layer 
is anatomically located between luminal blood flow and the underlying smooth muscle and 
extracellular components; therefore, the endothelium functions as a mechanically sensitive 
signal transduction interface between hemodynamic stresses and the vasoactive smooth 
muscle layer. On the basal aspect of the endothelium lies the extracellular matrix of the 
basement membrane, which is composed of four major classes of macromolecules: 
collagens, elastins, proteoglycans, and structural glycoproteins (89). The ECM functions 
to influence EC adhesion, spreading, migration, protein synthesis, proliferation, and 
differentiation (reviewed in 175). Other functions of the endothelium are maintenance of 
anticoagulant non-thrombogenic properties, control of lumen diameter and tissue 
perfusion, regulation of vascular permeability, metabolism of vasoactive substances, 
production of connective tissue and growth factors, and initiation of signal transduction 
cascades stimulated by acute inflammation, wound healing, and localization of 
atherosclerotic foci (35, 154).
The media is composed of SMCs oriented radially around the vessel 
circumference. Primary roles for the SMC layer include maintenance of arterial tone, 
synthesis of connective tissue and cholesterol, lipid metabolism, and reaction to vasoactive
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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agents through vasodilation or constriction (154). In both cell culture and the intact wall, 
SMCs can express two different phenotypes: a synthetic phenotype in which secretion is a 
primary function, and a contractile phenotype which is associated with vessel contraction 
and relaxation. Morphological alterations in the vascular wall from hypertension (95), 
atherosclerotic intimal thickening (54), and flow-mediated wall remodeling (179) primarily 
involve growth and proliferation o f medial SMCs. Individual ECs and SMCs are 
surrounded by extracellular connective tissue, comprised of similar components as the 
ECM at the EC-SMC interface. The extracellular connective tissue is involved in cell-cell 
signal transmission and syncytial cellular coordination. The outlying adventitia contains 
many lymphatic channels and nerve fibers that help innervate the vessel wall. The 
adventitia is also highly vascularized and provides the vessel wall with nutrients as well as 
growth factor and cytokine production (154).
Arterial Remodeling
Vessel wall remodeling can be broadly defined as any reorganization of wall 
components involving both increases and decreases in wall area. Remodeling can be 
viewed in terms of 1) gross network changes involving alterations in vessel length, 
vasculogenesis and/or angiogenesis, vessel arborization, and vessel rarefaction; or 2) 
organizational changes involving medial wall hypertrophy, intimal thickening, luminal 
enlargement, and ECM and/or connective tissue restructuring. Cellular mechanisms 
behind these gross morphological changes can include EC and SMC hyperplasia, cellular 
hypertrophy, cellular migration, cell lysis and death or apoptosis (32). Changes involving 
nuclear ploidy may also occur consistent with alterations in cell mass. Remodeling is an 
active process that enables the vessel to accommodate to changes in the local environment
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in order to maintain normal vessel geometry and tissue perfusion (160). Control of arterial 
remodeling is multifactorial and depends on factors such as cytokines, growth factors, 
neurotransmitters, hormones, autacoids, and mechanical forces (32). This multifactorial 
control, however, predisposes remodeling to be incongruous throughout the vasculature. 
Inter- and intra-vascular heterogeneity of structural remodeling has been examined in 
experiments using whole animals, cultured cells and organs, and in models of arterial 
injury and hypertension (reviewed in 32).
Biophysical Forces in the Vasculature
Biophysical forces in the vascular system can be described as stresses acting upon 
cellular and extracellular components o f  the vessel wall. Stress is defined as any force 
acting per unit area, and in the vasculature may be manifested as pressure and compression 
acting normal to a surface, frictional shear at the surface, and opposing tensile stresses 
acting outward from the surface (39). Circumferential wall stress, or hoop stress (o), acts 
normal to the cell surface and creates a force in a circumferential direction on the cross- 
section of the vessel. This compressive force is sensed primarily by the elastic, 
collagenous, and smooth muscle load-bearing components of the subendothelial wall. 
Using the LaPlace relation and assuming isotropic conditions exist in the vessel wall, 
circumferential wall stress is directly proportional to wall tension [the product of 
transmural pressure (P) and vessel inner radius (r)] and inversely proportional to vessel 
wall thickness (w). The equation for circumferential wall stress is a  = Pr/w; therefore, 
under conditions of increased pressure, wall stress can be normalized through an increase 
in vessel wall thickness (36, 109). In addition, if local pressure is held stable, luminal 
enlargement concomitant with increases in medial wall thickness can offset any changes in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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wall stress. Estimates for wall stress in arterioles and venules range between 0.5 - 10 x 
10s dynes (dyn) per square centimeter (cm2; ref. 165).
In comparison, shear stress (t) is a frictional, tangential force exerted by blood 
flow on the luminal aspect of intimal ECs in the same direction as blood flow. This stress 
is sensed primarily by intimal ECs which can transfer this stimulus into internal stresses 
that may be transmitted to abiuminal sites of attachment or to neighboring ECs through 
biochemical cascades or cytoskeletal activation. Transduction of these stresses to the 
underlying smooth muscle layer or to adjacent ECs may occur through mechanically- 
sensitive focal adhesion sites (38) and/or through metabolic and electrical coupling via gap 
junctions (36). In addition, medial SMCs have been found to be directly exposed to shear 
stress through interstitial fluid flow movement (3). Using the Poiseuille-Hagen relation 
and assuming complete laminar flow with a Reynold’s number less than 2000, wall shear 
rate (y; sec'1) is directly proportional to fluid volume flow (Q) and inversely proportional 
to the vessel radius (r). The equation for WSR is y = (m + 2)Q/7tr3. The dimensionless 
factor m depends on flow conditions: m = 2 for laminar flow and m > 2 for turbulent flow 
(145). For conditions of constant fluid viscosity (p.), shear stress is proportional to WSR. 
The equation for laminar shear stress, therefore, is t = 4Qp/7tr3, and is measured in 
dyn/cm2. These equations indicate that under conditions of increased flow, a small 
increase in radius can restore WSR and shear stress to normal values. However, if vessel 
radius is held constant during periods of increased flow, a direct increase in shear stress 
occurs. Luminal shear stresses have been measured as negative values in regions of flow 
reversal, < 1 dyn/cm2 in veins and in regions of flow separation, and > 100 dyn/cm2 at 
bifurcations of larger arteries or during episodes of increased cardiac output or
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
7
hypertension (35, 36, 145). Shear stresses from interstitial fluid movement surrounds 
medial SMCs and have been calculated to range between 1 (188) and 10 dyn/cm2 (2). 
Homeostatic arterial luminal mean shear stress is continuously regulated through 
endothelial-dependent vasodilation at approximately 15 dyn/cm2 (109), which produces 
the lowest energy cost for propelling blood volume through a branched network.
In a homeostatic vascular system, blood flow is generally laminar with constant 
and predictable shear stresses. However, in areas of non-uniform geometry where 
arborization, bifurcations, and curved regions occur, flows tend to separate forming 
vortices and eddies characteristic of turbulent flow. In these regions, the frequency, 
magnitude, and direction of blood flow become chaotic, and shear stresses can fluctuate 
greatly and even form negative values in regions of flow reversal (36). Under transitional 
flow conditions, with Reynold’s numbers between 2000 and 3000, disturbed laminar flow 
can occur with complex flow lines and a wide range of shear stresses. Consideration of 
these various forms of blood flow is necessary when studying shear stresses in different 
levels of the vasculature. In addition, large conduit arteries convey blood flow that is 
pulsatile, corresponding to systole and diastole of the cardiac cycle; therefore, large 
vessels are exposed to a range o f shear stresses and stress gradients when compared to the 
steady flows found in the smaller arteries and in the microcirculation. Nevertheless, 
Barbee et al. (12), using atomic force microscopy to study the luminal surface of 
endothelial cells exposed to varying flow conditions, defines blood flow as “quasi-steady” 
and approaching laminar near the EC luminal plasma membrane even in pulsatile large 
artery flow.
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Studies on Flow-mediated Vascular Remodeling
The influence of blood flow on the vascular system has been studied for over a 
century. Thoma, in 1893, found a significant correlation between the diameter of a chick 
embryo vessel and the blood flow that it conveys (referenced in 59, 77). Thoma 
discovered that, during angiogenesis, blood vessels with the fastest blood flow rates 
became the dominant arteries while the vessels with slower flow rates constricted and 
eventually atrophied. Early works by Schretzenmayr, Fleisch, and Hilton (referenced in 
166, 168) attributed flow-induced dilation during functional hyperemia in large arteries to 
a vascular reflex or to a conducted process through the vessel wall. Other early 
investigators studied the influence of blood flow on the state of constriction of vessels 
using various models such as arteriovenous fistulas (63, 144) and vasculogenesis and 
angiogenesis in the collateral circulation (100, 190). In 1975, Rodbard suggested that the 
endothelial layer of arteries senses increased blood flow and releases a vasodilating 
substance that acts on the medial smooth muscle to cause dilation (152). More recent 
studies using various in vivo and in situ  models have determined that a significant 
correlation exists between blood flow and the extent of vessel dilation (67, 91, 92, 114, 
139, 167, 168). More specifically, the degree of constriction of an artery has been 
determined to be inversely proportional to the blood flow conveyed through it.
Arterial ECs are the primary sensors for the fluid flow shear stress stimulus acting 
to regulate flow-induced vascular dilation. Smiesko et al. (167), using a canine femoral 
arteriovenous shunt model whereby femoral artery blood flow could be manipulated, 
showed a marked 15.8 + 2.7% increase in femoral artery diameter when blood flow 
increased from 10 to 293 ml-min'1. The response time for complete dilation was
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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approximately 80 seconds, and was preceded by an initial constriction o f  the vessel for 
approximately IS seconds. After the luminal endothelium was removed by a balloon 
technique, the flow stimulus failed to cause any significant dilation response. The authors 
found that removal o f the endothelium did not cause the artery to lose its basal tone, and 
concluded that based on their model using large conduit femoral arteries, an intact 
endothelium is necessary to permit flow-mediated arterial dilation. Similarly, Pohl et al. 
(137), using a canine femoral arteriovenous shunt model, induced approximately a 5-fold 
increase in femoral blood flow resulting in a transient latent response period followed by a 
significant vasodilation response in the presence o f normal pressure. This response was 
completely abolished by both mechanical removal of the endothelium (via balloon 
catheter) and by chemical inactivation of the endothelium (via hydrogen peroxide 
treatment).
Hull et al. (67), using femoral-external jugular and saphenous artery-external 
jugular arteriovenous shunts in dogs, induced a 10-fold increase in blood flow causing 
significant 9% and 15% increases in femoral and saphenous artery diameters, respectively. 
These dilation responses consisted of transient decreases in arterial diameter 
corresponding to an initial drop in pressure, followed by rapid relaxation o f the vessels in a 
manner proportional to the blood flow increase. A significant decrease in femoral arterial 
pressure occurred upon establishment of the arteriovenous shunt; however, this decrease 
in transmural pressure was found not to affect the dilation response. Also, an increase in 
pulse pressure was observed in this model, but this was also determined not to affect the 
response. Upon removal of the EC layer through mechanical rubbing, neither vessel 
dilated under increased flow conditions, suggesting a direct endothelial-dependent flow-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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induced dilation in these large vessels. Inhibition of phospholipase A2 by quinacrine 
attenuated the dilation response in a dose-dependent manner; however, cyclooxygenase 
inhibition through indomethacin treatment did not affect the response. These results 
indicate that the flow-mediated relaxation o f large vessel smooth muscle is related to 
activation of phospholipase A2, and may involve a non-prostaglandin metabolite of 
arachidonic acid.
In a similar study, Kaiser and Sparks (76), using the same femoral-external jugular 
and saphenous-external jugular arteriovenous shunt model in dogs, further characterized 
the influence o f the endothelium on flow-dependent arterial dilation. A cyclooxygenase 
and lipoxygenase blocker, 5,8,11,14-eicosatetraynoic acid (ETYA), caused irreversible 
inhibition of flow-induced dilation as well as significantly increasing the ED50 for 
acetylcholine-induced relaxation; however, indomethacin did not affect the dilation 
response. Exposure of the femoral and saphenous arteries to methylene blue, an inhibitor 
of guanylate cyclase activation, caused a dose-dependent decrease in the dilation response 
to flow. These results suggested that both cyclic GMP and a non-prostaglandin 
lipoxygenase-dependent arachidonic acid metabolite are involved in the response to flow. 
Based on the results using an H-l receptor antagonist tripelennamine, these authors 
believe that increased blood flow stimulates a local increase in histamine which binds to 
the H-l receptor and increases phospholipase A2 activity. This initiates a cascade of 
events leading to endothelial production and release of a non-prostaglandin arachidonic 
acid metabolite. This metabolite, in turn, stimulates EDRF which activates a vascular 
smooth muscle guanylate cyclase to increase cyclic GMP resulting in large vessel 
relaxation.
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Comparable studies have been performed investigating the significance of reduced 
blood flow on large vessels. Guyton and Hartley (58) used flow-restricting silver clips in 
vivo to alter unilateral carotid blood flow in juvenile rats. After 6 weeks of development, 
carotid arterial diameters increased 36% on the flow-restricted side and 62% on the 
contralateral control artery. After 12 weeks o f development, changes were not 
significantly larger than at the earlier time point of 6 weeks. Overall flow reduction 
averaged 35% corresponding to an overall decreased diameter growth averaging -10.2% 
of the contralateral control carotids. Cross-sectional area of the tunica media was 
significantly reduced on the flow-restricted artery, yet the medial area to circumference 
ratio (which is proportional to vessel wall thickness) did not change. These results infer a 
direct relationship between blood flow, vessel dilation, and vessel wall growth in 
developing rats. Additionally, these authors found that the flow-induced changes 
correlated best with net changes in flow pulsatility and were not correlated with changes 
in mean flow velocity. They suggest that oscillatory shear stress is the primary force 
leading to flow-mediated arterial changes. Langille et al. (91) compared the adaptive 
responses of external carotid arteries following 70 - 80% flow reductions in weanling and 
mature rabbits. After 1 month of flow restriction (-79%) in the presence of normal arterial 
pressure, young rabbits experienced significant reductions in ipsilateral carotid artery DNA 
levels (-35%), elastin content (-38%), wall mass (-30%), and internal diameter (-31%) 
when compared to contralateral control carotid arteries. In mature rabbits, a decrease in 
intimal endothelial cell number (-15%) after 1 month and a decrease in internal diameter (- 
21%) of the ligated carotid artery was observed at 1, 2, and 4 weeks after flow 
obstruction, yet no significant differences were seen in medial or adventitial constituents.
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These authors suggested that blood flow alterations occurring during weanling 
development may modulate proliferation of cellular and extracellular vessel wall 
components as well as normal flow-mediated dilatory responses. Pharmacologic 
interventions indicated that adult responses to decreased flow may involve two phases: a 
transient, papaverine-sensitive response, vasoconstrictor in origin, followed by a sustained, 
papaverine-insensitive structural reduction in diameter consisting of cellular remodeling. 
Treatment with indomethacin and captopril implied that neither prostaglandins nor a local 
renin-angiotensin system were involved in these responses. Also, manipulation of local 
flow conditions indicated that vessel responses were consistent only with changes in mean 
flow velocity, not pulsatile flow.
In a similar study by Langille and O’Donnel (92), ligation of the left external 
carotid artery yielded a 70% reduction in common carotid blood flow in rabbits with no 
significant change in flow through the contralateral common carotid. After 2 weeks of 
flow restriction, the reduced flow vessel exhibited a 21% decrease in lumen diameter when 
compared to the normal flow contralateral artery. Results from papaverine administration 
suggested that the reductions in carotid diameter after 2 weeks of flow reduction may 
reflect structural remodeling of the arterial wall rather than prolonged constriction of the 
medial smooth muscle. Complete abolition of the diameter reduction from diminished 
flow occurred upon removal of the intimal endothelial layer by both mechanical (balloon 
catheter) and chemical (Triton X-100) methods. These results support the vital role for 
intimal endothelium in sensing flow alterations and relaying the message for medial smooth 
muscle dilatory responses. In a more recent study from the same laboratory (186), 
common carotid artery ligation resulted in an 80% decrease in flow through the ligated
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artery, corresponding to a 73% decrease in calculated shear stress. This reduced EC 
density by 33%, coincident with an 18% decrease in diameter after S days. This vessel 
also exhibited a substantial number o f monocytes adhering to the endothelial surface at 
cell-cell junctions which appeared to be migrating across the endothelium into the 
subintimal space. This may be significant since monocyte adherence and transmigration, 
and subsequent differentiation into macrophages, are early events in the atherogenesis 
process. The contralateral carotid artery exhibited a 123% increase in blood flow, 
corresponding to a 170% increase in calculated shear stress. The contralateral carotid, 
despite these large increases in flow, did not significantly dilate after 5 days, and luminal 
EC density was not altered when compared to sham controls. Considering the studies 
discussed above, the vital role of luminal ECs in mediating the direct dilatory responses 
from high flow conditions in large conduit vessels is substantiated.
In addition to the investigations described above on large conductance and feed 
vessels, other studies have addressed the impact of flow on smaller microvascular arteries 
and resistance arterioles. Smiesko et al. (168), using rat mesenteric arcading arterioles 
(control lumen diameters 40 - 110 pm) exposed to increased blood flow velocity (-570%) 
through collateral circulation in vivo, found a significant 70% flow-dependent vasodilation 
after a short latent period. The dilation response lasted for the duration of the experiment 
(-10 min), and was significantly correlated with red blood cell velocity, blood flow 
volume, and calculated WSR. Arcading arteriolar WSR increased from 722 sec*1 to 5156 
sec*1 with establishment of the collateral circulation pathway. These authors proposed that 
there may not be a controlled stable set point for WSR in mesenteric arcading arterioles.
Roller and Kaley (84), using parallel occlusions in third-order arterioles of rat
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cremaster skeletal muscle (mean control diameter 22.5 pun), induced a 230% increase in 
calculated arteriolar blood flow in the presence of normal arterial pressure. This resulted 
in an immediate 87% increase in calculated WSR and, following a brief (6 - 15 sec) latent 
period whereby diameter actually decreased, a significant 31% increase in arteriolar 
diameter. This increase in vessel diameter subsequently decreased the calculated WSR to 
approximately 46% over that of controls. In the presence of an intact endothelium under 
control flow conditions, the distribution of data was monotonic and calculated WSR was 
not correlated with arteriolar diameter. This suggests that during normal homeostatic 
conditions, WSR, and therefore shear stress (in the presence of stable blood viscosity), 
may be a controlled parameter in skeletal muscle microvascular networks. In addition, 
during periods of increased blood flow velocity, flow-dependent dilation occurs to 
regulate shear stress towards a pre-determined set point. Local impairment of the 
vasoactive functions of the endothelial layer through mercury light-sodium fluorescein 
(light-dye) treatment resulted in a slight decrease in control lumen diameter with a 
subsequent 36% increase in control calculated WSR when compared to control values 
with an intact endothelium. Arteriolar occlusion and increased flow showed complete 
abolition of the flow-induced dilation, corresponding to a highly significant 290% increase 
in calculated WSR This increased WSR was not regulated or compensated for (through 
dilation) as when the endothelium was intact, supporting a role for endothelial regulation 
of WSR (and shear stress) in the microvasculature.
Comparison between flow-induced alterations in normal versus spontaneously 
hypertensive rats was performed by Qui et al. (139) on mesenteric conductance arteries 
(mean control diameter 500 p.m). Using an in situ perfused mesenteric arterial tree, and
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controlling mesenteric blood flows between 0.2 and 4.0 ml/min, intraluminal mesenteric 
pressure was found to increase linearly with flow in both normal and hypertensive rats, 
with absolute pressures for the hypertensive animals significantly higher. There was a mild 
trend for an increased diameter with flow in both normal (5%) and hypertensive (4%) rats, 
although no difference existed between the two populations. Removal of the luminal 
endothelium by CO2 gas infusion resulted in increased arterial resistance in both rat strains, 
with a decreased lumen diameter only in the normal rats. Administration o f L-NAME to 
inhibit NO synthesis did not alter mesenteric pressure in either strain. L-NAME 
significantly decreased conductance arterial diameter during flows of 0.2 and 2.0 ml/min in 
normal rats while not having any effect on diameters in the hypertensive rats. Results 
from this in situ model using both normotensive and hypertensive rats suggests that 
luminal endothelium plays similar roles in the control of mesenteric arterial resistance in 
both strains, and that conductance arteries from normal rats exhibit significant flow- 
diameter dependency which is adversely altered by both endothelium removal and NOS 
inhibition. In contrast, in hypertensive rats the diameter-flow relationship was not 
susceptible to alterations induced by L-NAME or by removal of the endothelium. In both 
strains, a positive interaction was discovered between flow-induced vessel dilation and 
increases in mesenteric transmural pressure.
Through establishment of a unique unilateral orchidectomy model in developing 
rats whereby blood flow was decreased subsequent to a decreased demand, Wang and 
Prewitt (187) analyzed microvascular cremaster arterioles during normal development and 
in the presence of reduced blood flow. Three weeks after performing the orchidectomy. 
and using arterioles of the intact contralateral cremaster muscle for controls, total
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ipsilateral blood flow was reduced approximately 44%, yet flow per gram of tissue 
remained stable. The reduced flow yielded inhibition of normal vascular development as 
evidenced by the following: the lumen diameters of feeding (1A), arcading (2A), 
precapillary (3 A), and transverse (4A) arterioles; the number of 4As per 3 A  and the 
cross-sectional wall areas o f 1A 2A  and 3 A arterioles, were all diminished when 
compared to controls. The authors speculated that the decreased blood flow resulted in a 
diminished shear stress, which alone or in combination with an altered production of 
metabolic growth factors, mediated the flow-dependent arteriolar growth retardation. In 
addition, a significant correlation was found between cross-sectional wall area and relaxed 
(10'3 M adenosine) internal diameters for all 4 orders of cremaster arterioles. In summary, 
results from these studies have substantiated the role of intimal ECs in sensing fluid shear 
stress and in mediating responses of the adjacent medial smooth muscle layer in both large 
and small vessels.
Mechanisms of Flow-mediated Vascular Remodeling
Considering the location of the endothelium and its vital role as a biomechanically 
responsive interface between flow-mediated shear stress and the medial wall, most 
experiments performed on shear stress have utilized cultured ECs from a variety of 
sources. These experiments generally use a cone-plate viscometer, a parallel-plate 
viscometer, or a capillary tube viscometer to expose the grown endothelial monolayer to 
controlled shear stresses (109, 148). The cone-plate viscometer has the advantage of not 
exposing ECs to a hydrostatic pressure component (in addition to shear stress). When the 
endothelium is exposed to increased shear stress, diverse responses occur ranging from 
immediate changes (msec) to prolonged chronic changes (hours to days). Rapid responses
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include primarily biochemical and electrophysiological events such as changes in ionic 
conductance, inositol triphosphate generation, adenylate cyclase activity, activation of 
guanosine 3’,5’-cyclic monophosphate (cGMP), elevation of intracellular free calcium, 
release of neurotransmitters including substance P, ATP, and acetylcholine, and the release 
of significant amounts of NO and prostacyclin necessary for smooth muscle-dependent 
dilation (12, 35, 37, 165). Evidence indicates these early responses to flow act primarily 
to initiate second messenger cascades, induce vasotonic adjustments, and start EC 
deformation as an auto-regulatory mechanism to decrease the amount o f shear stress to 
which the endothelium is exposed (148, 166). Secondary intermediate responses are 
primarily biological growth responses associated with transcription factor activation, 
regulation of gene transcription, protein synthesis, and changes in cell cycle kinetics. 
Initiation of gene transcription for factors such as c-fos, c-jun, endothelin-1, nuclear factor 
kappa B, eNOS, tissue plasminogen activator, TGF-pl, monocyte chemotactic protein, 
bFGF, and PDGF all occur within minutes to several hours after onset of the stimulus (35, 
148, 165). These secondary responses can also include stimulation of pinocytosis, 
initiation of cytoskeletal reorganization, focal adhesion rearrangement, and diverse cell- 
wide adaptive responses. Delayed responses represent chronic cellular adaptations to new 
hemodynamic conditions and include permanent cytoskeletal reorganization and cell 
alignment, organelle redistribution, normalization of mRNA levels, increased mechanical 
stiffness, and extracellular matrix restructuring with changes in thrombomodulin, collagen, 
and fibronectin synthesis (35, 37, 148).
Endothelial mechanotransduction of a shear stress stimulus generally operates via 
one of two mechanisms, or most likely through a combination of both, and involves many
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of the factors cited above. The first pathway involves shear stress-generated force 
transmission through cytoskeletal components acting to distribute the sensed stimulus to 
the nucleus, to neighboring ECs, or to abluminal focal adhesion sites of attachment on the 
substratum. Luminal transmembrane proteins are stimulated by shear stress leading to 
conformational changes in vimentin-rich intermediate filaments and F-actin stress fibers 
(35). On the abluminal focal sites, conformational changes in these microfilaments can 
activate, through various linker proteins (talin, vinculin, paxillin, a-actinin), membrane 
integrins associated with both the intracellular and extracellular environments. This could 
lead to rapid transmission of the stimulus through the substratum to the medial SMC layer 
and subsequent responses (37). The second pathway involves force signal transduction 
through the EC involving luminal membrane signaling and second messenger stimulation. 
This, in turn, initiates a biochemical signaling cascade leading to nuclear gene regulation 
and adaptive responses. The membrane signaling step entails sensing the shear stress 
stimulus through a shear stress-sensitive ion channel, possibly a non-specific stretch- 
activated antiport channel allowing sodium and calcium entry with potassium removal 
from the EC (93), or a shear-dependent opening of a potassium channel leading to 
hyperpolarization of the cell coincident with calcium entry (128, 131). This initial 
response can initiate a biochemical cascade involving phosphatidylinositol metabolism, 
cyclic GMP, protein kinase C, and activation o f nuclear transcription factors such as 
nuclear factor kappa B, activator protein-1, and a shear stress-sensitive response element 
(34, 37). These, in turn, may regulate gene activation for such factors as PDGF, TGF-P1, 
immediate early genes (c-fos, c-jun, egr-1), tissue plasminogen activator, endothelin-l,
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monocyte chemotactic protein-1, vascular cell adhesion molecule-1, intracellular adhesion 
molecule-l, and NOS (34, 35, 37).
In addition to these experiments aimed at analyzing the influence of shear stress on 
ECs, several investigators have recently discovered that medial SMCs in intact blood 
vessels can directly experience shear stress (3, 4, 188). These authors have shown that 
SMCs can be exposed to shear stresses up to 10 dyn/cmz as a result of interstitial fluid 
flow driven by the transmural pressure gradient across the medial wall. The impact of 
shear stress on medial SMCs may stimulate similar biochemical factors as those cited 
above for the endothelium; however, further work needs to be done in examining the 
direct impact of shear stress on SMCs.
Through a derivation in the LaPlace relation, vasoactive flow-mediated luminal 
expansion can increase circumferential wall stress. Experiments analyzing the impact of 
wall stress on vessel remodeling have been performed on ECs and SMCs from a variety of 
experimental preparations (reviewed in 165). Both ECs and SMCs exposed to wall stress 
experience similar responses compared to those discussed above for shear stress. These 
include ion channel activation, protein phosphorylation, second messenger signaling, gene 
activation, growth factor induction, and cellular structural remodeling (165). Several 
recent reviews offer thorough comparisons of these and other mechanical stresses and 
their roles in vessel remodeling (46, 121, 165).
Endothelial Nitric Oxide Synthase
Nitric oxide is an endothelium- and smooth muscle-derived vasoactive factor that 
was originally identified by Furchgott and Zawadzki in 1980 (49). Based on their
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experiments using rat isolated aortic rings, results suggested acetylcholine stimulated ECs 
to release an “endothelium-derived relaxing factor” that induced vessel relaxation. This 
mediator was later identified as nitric oxide by Furchgott and others (47, 69). Nitric oxide 
contributes to the regulation o f local and systemic vascular resistance, distribution of 
blood flow and oxygen delivery, electrolyte balance, and regulation of arterial pressure 
(178).
Nitric oxide is synthesized by vascular ECs and SMCs from one of the two 
terminal guanidino nitrogens of L-arginine following its conversion to L-citrulline by a 
nitric oxide synthase enzyme complex. Three isoforms of NOS have been identified which 
share <59% homology in terms o f human amino acid sequences (43). Isoform I of NOS 
has been referred to as bNOS (brain) or cNOS (constitutive and/or Ca2+-regulated), but is 
commonly termed nNOS (neuronal). Isoform I is constitutively expressed in neuronal and 
certain epithelial cells and is regulated by Ca2+ and calmodulin. Isoform I functions 
indirectly to regulate synaptic transmission of the CNS, mean arterial blood pressure, and 
smooth muscle relaxation and vasodilitation via peripheral nitrergic nerves (43). Isoform 
H is not constitutive but can be induced by various cytokines and bacterial 
lipopolysaccharide in a variety o f cells. This isozyme is thus referred to as inducible NOS 
(also known as macNOS for the macrophage cell type). Isoform II is not dependent on 
Ca2+-calmodulin. This isozyme acts to inhibit iron-containing enzymes and is involved in 
DNA fragmentation and in the pathophysiology of autoimmune diseases and septic shock 
(43). Both isoforms I and II are predominantly soluble enzymes, and both use molecular 
oxygen, NADPH as a cosubstrate, and FAD, FMN, and 6(R)-5,6,7,8-tetrahydrobiopterin 
as cofactors (178).
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Isoform QI of NOS normally accounts for both constitutive basal and stimulated 
NO synthesis in ECs throughout the vasculature (24, 43). This isozyme is more than 90% 
particulate (45); however, eNOS can be phosphorylated in response to certain agonists 
which induce translocation o f the enzyme from the membrane-bound particulate fraction 
to the cytosolic subcellular fraction (116). Post-translational modifications of eNOS 
include palmitoylation and myristylation which, along with Ca2+-calmodulin and 
intracellular pH, aid in its regulation. The addition of palmitic acid to eNOS has been 
shown to cause localization of the enzyme to endothelial caveolae (50), and 
depalmitoylation of eNOS was found to induce cytosolic translocation and subsequent 
phosphorylation (151). Sessa et al. (164) recently reported that eNOS is a Golgi- 
associated protein in cultured aortic and vein ECs and in intact vessels, and this membrane 
association is necessary for efficient synthesis of NO. Venema et al. (183), however, 
suggested that membrane association of eNOS functions to inhibit its catalytic activity by 
interfering with its calmodulin-binding domain. Isoform III of NOS uses heme, molecular 
oxygen, NADPH, FAD, FMN, and tetrahydrobiopterin as cofactors (178). Normal 
homeostatic conditions of the EC allow for basal levels of NO production through eNOS 
which continually regulates vascular resistance and maintains arterial tone. This occurs 
through stimulation of soluble guanylyl cyclase and modulation of cGMP in vascular 
SMCs (44, 70). Basal levels of NO produced from eNOS, as well as NO release through 
nitrergic nerves, serve to counterbalance the vasoconstriction normally produced by the 
renin-angiotensin system and the sympathetic nervous system. Basal release of endothelial 
NO also serves to maintain a nonthrombogenic vascular environment by inhibiting platelet 
aggregation and platelet and leukocyte adhesion to the vessel wall (5, 140, 141). Nitric
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oxide has been found to stimulate DNA synthesis in microvascular ECs (198) as well as 
directly mediate angiogenesis and EC growth and migration (97, 199). In contrast, 
eNOS-mediated NO production has been shown by several investigators to inhibit DNA 
synthesis, mitogenesis, and proliferation of vascular SMCs (SI, 52, 122). A negative 
feedback mechanism has been suggested for NO synthesis, as the addition o f NO and NO 
donors non-competitively inhibit eNOS activity and endothelial NO production in 
response to receptor-dependent agonists and increased flow (8). Considering the role of 
hemodynamic stresses in regulating eNOS, the 5’-promoter region of eNOS contains a 
putative acute-phase shear stress response element similar to the SSRE found in PDGF 
and other shear stress-responsive genes (110).
Flow-induced increases in NO transcription and stimulation of NO production and 
release have been substantiated by numerous investigators using in vitro, in vivo, and 
isolated intact vessel preparations (27, 28, 62, 78, 87, 88, 103, 127, 130, 169); however, 
the regulation of eNOS by shear stress has only recently been investigated. This NO- 
dependent vasoactive relaxation in response to elevated blood flow acts as a feedback 
mechanism to restore wall shear stress towards normal homeostatic levels. Alternatively, 
any decrease in vessel diameter at constant flow would increase local shear stress, with 
subsequent endothelial NO-mediated vessel relaxation offsetting the original 
vasoconstriction (24).
Nishida et al. (126), in an initial attempt to characterize eNOS mRNA and protein 
expression, exposed BAECs to 15 dyn/cm2 for 24 hours using a parallel plate viscometer. 
Northern and Western analyses revealed significant increases in eNOS mRNA transcript 
levels and eNOS protein expression in cells exposed to increased shear stress compared to
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static controls. These increases in eNOS activity then, through production and release of 
NO, could have direct influence on shear stress-mediated endothelium-dependent vascular 
relaxation. A subsequent study by the same laboratory (177) attempted to characterize the 
mechanisms, time course, and dose response characteristics o f these shear stress-induced 
increases in eNOS. In this study by Uematsu et al. (177), BAECs and HUVECs were 
grown on a parallel plate viscometer and exposed to shear stresses varying between 1.2 
and 15 dyn/cm2 for I to 24 hours. A 3 hour exposure to 15 dyn/cm2 yielded an 
approximate 270% increase in eNOS mRNA versus static controls and directly increased 
eNOS mRNA levels in a dose-dependent manner. Results from administration of gene 
transcription inhibitors, potassium channel antagonists, and PK-C inhibitors suggested that 
shear stress-induced eNOS expression is dependent on de novo gene transcription, is 
regulated by potassium channel opening, and may not require PK-C activation. In 
addition, analysis of endothelial cell nitrite production indicated an increased capacity of 
the ECs to release NO upon exposure to shear stress.
Ranjan et al. (142) attempted to characterize the influence of shear stress on eNOS 
expression in BAECs and HUVECs. Using a parallel plate viscometer, eNOS peptide 
expression was elevated after a 3 hour exposure to 25 dyn/cm2. This increase remained 
through 12 hours of flow exposure. Shear stress exposure to 4 dyn/cm2 did not elicit any 
significant increase in eNOS protein levels in either cell type. Endothelial NOS mRNA 
levels were found to be elevated 2- to 3-fold after 6 and 12 hours’ exposure to both 4 and 
25 dyn/cm2. Using dexamethasone to suppress the inducible function of eNOS, results 
indicated that all shear stress-mediated responses were specific for constitutive activation 
of eNOS. Results from various pharmacologic interventions suggested that flow-induced
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NO was not involved in a positive feedback mechanism to cause an increase in eNOS, nor 
was PK-C activation necessary for the shear stress-mediated responses evidenced in this 
study.
The influence of cyclic strain on eNOS activity has recently been studied by 
Awolesi et al. (9, 10) using cultured BAECs. Endothelial cells subjected to deformation at 
60 cycles/min with 6 and 10% strain exhibited upregulation of both eNOS transcripts and 
protein levels after 24 hours (9). In order to examine whether this upregulation was 
translated into functional activity, this same group analyzed ECs exposed to 10 and 24% 
strain for 24 hours (10). Nitric oxide production was indirectly assessed by measurement 
of L-citruIline accumulation and by measuring total nitrite in the media (according to the 
Greiss reaction). Results demonstrated that cyclic strain increases NO production through 
stimulated eNOS activity in cultured BAECs.
Recently, an interesting study was published considering the influence of NO on 
bFGF in inducing growth of aortic SMCs. Hassid et al. (61) exposed primary cultures of 
rat aortic SMCs to several agents capable of activating the cGMP pathway. These agents 
were found to stimulate bFGF-induced [3H]-thymidine incorporation by several-fold. 
These authors suggested that endogenous NO may act to amplify the mitogenic actions of 
bFGF in vivo. In addition, Morbidelli et al. (120) demonstrated that the mitogenic actions 
of VEGF on cultured coronary microvascular venular ECs are directly mediated by the 
presence of NO donors and inhibited by NOS antagonists. These results are supported by 
several investigators who found NO to be directly involved in cell replication and 
angiogenesis (97, 198, 199), but incompatible with the results indicating that NO alone 
inhibits growth and proliferation of aortic SMCs in culture (51, 52, 79, 122). Other
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vasodilators, including ANF and calcium channel antagonists, also inhibit mitogenesis and 
proliferation of cultured vascular SMCs (2, 25).
Platelet-derived Growth Factor
Platelet-derived growth factor is a 28 - 35 kD dimeric peptide secreted from 
SMCs, ECs, macrophages, and fibroblasts (155). PDGF exists as a disulfide-linked homo- 
(-AA or -BB) or hetero-dimer (-AB) which binds to specific high-affinity cell surface 
receptors on mesenchymal cells such as SMCs, ECs, fibroblasts, osteoblasts, and 
astrocytes (123, 16, 31). The PDGF receptors are composed o f two complimentary 
subunits, a -  and p-, which bind in the presence of a PDGF dimer to form three distinct 
receptors: a a , aP, and pp. Ligand specificity of the receptors dictates that PDGF-AA 
binds only to a a  receptors, PDGF-AB binds to a a  or aP receptors, and PDGF-BB binds 
to aP or PP receptors (123). Upon ligand-receptor binding, all three forms of PDGF can 
bind heparin, stimulate vasoconstriction and SMC mitogenesis, and enhance chemotaxis in 
SMCs, monocytes, and neutrophils (153, 155). Much research has focused on 
characterizing these mitogenic and chemotaxic properties of PDGF in various cell types 
under normal and stimulated conditions.
Under normal in vivo conditions, medial SMCs constitutively express low levels of 
PDGF-A mRNA (18), translated PDGF-AA protein (reviewed in 123), and PDGF-a and - 
P receptors (113). PDGF-A, however, can also be expressed in microvascuiar 
endothelium (18). In comparison, under both normal in vivo conditions (18) as well as 
during atherogenesis (192) PDGF-B transcripts are localized primarily to the endothelium 
with lower levels found in the media (104). Several laboratories found cultured arterial 
SMCs capable of transcribing PDGF message in addition to the -A form (125, 163, 185).
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Majesky et al. (104) found both PDGF-A and -B mRNA transcripts expressed in small 
amounts in normal newborn and adult rat aortic SMCs under in vivo conditions. In cell 
culture, PDGF-B transcripts accumulated in the SMCs of young rats with no PDGF-B 
expression observed in adult rat SMCs. Equal levels of PDGF-A mRNA were found in 
cultured SMCs in newborn and adult rats. These results suggested a differential 
expression of PDGF-B exists and may be related to the age of the animals. Barrett et al. 
(IS) found a 3.7 kilobase RNA homologous to the sis (PDGF) gene expressed at 
extremely low levels in BAECs m vivo, at minimal levels in HUVECs in vivo, and at 
moderate levels in cultured human and bovine ECs. This implies that the PDGF gene may 
become activated under m vitro conditions, and the authors suggested that PDGF may be 
involved in vascular development of young animals and in maintenance of a homeostatic 
vascular system in adult animals.
The influence of physiologic stresses on PDGF transcription and protein 
translation has been performed on ECs and SMCs in vivo and in cell culture using models 
of hypertension (123), atherosclerosis (72), mechanical strain (193) and injury (30), flow 
reduction (85, 107) and flow elevation (64, 65,66, 172). The remainder of this discussion 
focuses specifically on the effects of blood flow and its associated stresses on PDGF 
expression. Hsieh et al. (66), in 1991, investigated the effects of shear stress on PDGF-A 
and PDGF-B mRNA expression in primary HUVEC cultures. Under control conditions, 
the level of PDGF-A mRNA was negligible while a baseline level of PDGF-B mRNA 
expression was detected. Using a parallel plate flow viscometer and a physiologic level of 
shear stress (16 dyn/cm2), transient increases in PDGF-A (> 10-fold) and PDGF-B (2- to 
3-fold) mRNA occurred after approximately 1.5 hours and returned to baseline levels after
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approximately 4 hours. Shear stress “dose-dependency” was analyzed using exposure 
levels from 0 to 51 dyn/cm2 for 2 hours. Results showed a shear stress-dependent increase 
in both PDGF-A and PDGF-B mRNA between 0 and 6 dyn/cm2, with PDGF-A mRNA 
levels remaining elevated but steady between 6 and 51 dyn/cm2. PDGF-B mRNA levels 
subsequently declined between 6 and 31 dyn/cm2, then increased between 31 and 51 
dyn/cm2. These results showed PDGF-A and -B expression can be enhanced through 
increased shear stress in HUVECs m vitro. In addition, these authors found that shear 
stress-induced PDGF-A exists as two major transcripts (-2.5 and 3.0 kb) and two minor 
transcripts (~1.7 and 3.8 kb), while shear stress-induced PDGF-B exists as a single 
transcript (-3.7 kb).
In 1992, Hsieh et al. (65) investigated the signaling mechanisms behind shear 
stress-induced PDGF expression in HUVECs. Using a similar protocol as in the 
experiment described above (66), and with the use of various pharmacologic agents, 
results suggested that shear stress-induced PDGF-A and -B mRNA expression is mediated 
by a calcium/phosphoinositide-dependent diacyl glycerol-activation of PK-C in which 
heterotrimeric G-proteins may also play a role. Basal levels of PDGF (primarily -B) 
expression were also determined to be PK-C-dependent. Protein kinase C, then, was 
hypothesized to activate nuclear gene transcription for PDGF. Prostaglandin synthesis, 
extracellular calcium, and cyclic AMP- and cyclic GMP-dependent protein kinases, 
however, were not involved in the shear stress-induced responses. In a subsequent study 
by the same authors (64), HUVECs were exposed to a physiologic level of shear stress 
(-16 dyn/cm2) in pulsatile (1 Hz) and steady flows on a parallel plate viscometer. 
Although PDGF-A mRNA levels were low in stationary cells, expression increased (>10-
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fold) after 1.5 hours under both steady and pulsatile flows. PDGF-B mRNA levels were 
more abundant in stationary cells, and expression was also increased (<2-fbld) after 1.5 
hours under steady and pulsatile flows. Generally, steady flows elicited greater responses 
than pulsatile flows for both PDGF-A and -B transcripts. In this same study, 
hypothesizing that similar shear stress-induction mechanisms may exist for c-fos and 
PDGF, c-fos antisense technology was used to determine if c-fos regulates shear-induced 
PDGF induction. The antisense treatment completely abolished c-fos transcription 
without affecting PDGF mRNA induction, suggesting that flow-induced c-fos expression 
may not mediate flow-induced PDGF expression.
Further studies continued to elucidate the mechanisms of shear stress-induced 
PDGF expression. Mitsumata et al. (118) exposed BAECs to 30 dyn/cm2 for periods up 
to 24 hours in a parallel plate viscometer in an attempt to examine the influence of PK-C 
in PDGF expression. PDGF-B mRNA expression was increased after 3 hours of exposure 
to shear stress, and significantly elevated 13-fold after 6 hours’ exposure. PDGF-B 
mRNA levels remained significantly elevated for the duration of the experiment; however, 
control PDGF-A levels were quite low, and no significant changes in PDGF-A expression 
were observed at any time point during the experiment. Through the use of various 
pharmacologic agents that activate or inhibit PK-C, results suggested that both PK-C- 
dependent and PK-C-independent pathways exist that are capable of inducing PDGF-B 
mRNA expression in BAECs exposed to shear stress. In addition, these authors found an 
interesting result pertinent to the present study. Treatment of the ECs with TGF-fl (0.1 - 
10 ng/ml) stimulated PDGF-B mRNA expression without affecting PK-C levels. In 
addition, in contrast to the results from Hsieh et al. (64) where c-fos mRNA expression
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was significantly elevated after 30 minutes’ exposure to shear, in this study 30 dyn/cm2 did 
not alter c-fos expression at any time point.
Resnick et al. (147) used a cone-plate flow viscometer to expose BAECs to 10 
dyn/cm2 for 4 hours, and elicited a significant increase in PDGF-B mRNA. The promoter 
region of the human PDGF-B chain gene was found to contain the necessary elements for 
flow-responsiveness through use of a transfected reporter gene. Using a series of mutant 
human PDGF-B promoter (1.3 kb)-chloramphenicol acetyltransferase (CAT) reporter 
gene constructs transfected into ECs, these authors discovered a c/s-acting component in 
the PDGF-B promoter region that is necessary for shear stress-responsiveness. This shear 
stress response element contains a six base pair core-binding sequence that binds to shear 
stress-induced transcription factors leading to gene expression. This transcription factor 
binding site (or its compliment) has been found in the promoters of other shear stress- 
induced factors such as endothelin-1 (108), tissue plasminogen activator, the nuclear 
protooncogenes c-fos and c-jun, monocyte chemotactic protein, and intracellular adhesion 
molecule I (reported in 147). Halnon et al. (60) exposed BAECs to shear stress (10 
dyn/cm2) in an effort to analyze the mechanism of PDGF-A mRNA induction. Shear 
stress elicited a several-fold increase in PDGF-A mRNA after 2 hours. CAT-reporter 
gene constructs transfected into ECs caused a two-fold increase in activity with exposure 
to shear stress, suggesting that shear stress-induced upregulation of PDGF-A mRNA is 
due in part to transcriptional activation. A SSRE specific for PDGF-A is thought to exist 
independent of the SSRE identified for PDGF-B, but this element has yet to be defined.
Considering the mechanisms of PDGF induction, Miano et al. (I IS) used a balloon 
injury model in rat aorta and found increased SMC c-myc and thrombospondin after 2
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hours. This was followed by increased mRNA expression for PDGF-A TGF-01, and a 
bFGF receptor. Seven days after initiation of the injury, a spontaneous increase in c-myc 
and thrombospondin mRNA was detected again, followed 12 hours later by a significant 
increase in SMC DNA replication. These authors suggested that an autocrine mode of 
growth factor-stimulated SMC proliferation exists in vivo, and that immediate early genes 
act to regulate this process. This corroborates the findings of Reidy and coworkers (185) 
who demonstrated PDGF-induced SMC proliferation after arterial injury occurs in vivo 
through autocrine action affecting primarily intimal-associated SMC. In addition, 
Khachigian et al. (81) determined that egr-1, a serum-inducible phosphoprotein that acts 
as an “early growth response gene”, is stimulated through mechanical injury to displace 
the Sp-l site on the PDGF-B promoter. This, in turn, upregulates PDGF-B in ECs 
exposed to mechanical vascular injury.
In contrast to the results discussed above concerning PDGF induction from 
exposure to shear stress, Malek et al. (107), using a cone-plate viscometer and cultured 
BAECs, found PDGF-B mRNA expression to decrease significantly 3.9-fold and 4.2-fold 
after 9 hours’ exposure to steady laminar shear stress at levels of 15 and 36 dyn/cm2, 
respectively. This decrease, however, was preceded by a transient nonsignificant increase 
in PDGF-B mRNA at 30 minutes, followed by a return to control levels by I hour with 
subsequent decreases through 9 hours. PDGF-A mRNA expression was not detected in 
this cell line, consistent with the findings of Mitsumata et al. (118), yet contradictory to 
the results from Collins et al. (26) and Halnon et al. (60) on shear stress-induced ECs. No 
differences were observed between responses to steady and pulsatile flows (average -15 
dyn/cm2) or between laminar and turbulent flows, in terms of PDGF-B inhibition. These
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authors suggested that the magnitude o f shear stress is more important in growth factor 
regulation than the dynamic characteristics of the shear stress stimulus. In addition, 
temporal variation in the shear stress-regulation of PDGF mRNA expression may be 
evident considering the general trend for early PDGF induction (64, 65, 66, 147) followed 
by inhibition of PDGF mRNA expression (107). In a separate study by Kraiss et al. (85) 
using flow alterations in baboon aortoiliac prosthetic grafts, PDGF-A mRNA levels were 
significantly elevated in low-flow grafts compared to high flow grafts. Results from ICC 
and ISH indicated the increased PDGF-A protein and transcript levels were localized to 
the luminal endothelium and subjacent SMC layer. These authors proposed that abrupt 
reductions in blood flow induce accelerated neointimal thickening which may be 
temporally and anatomically regulated by PDGF-A Similar results were found by 
Majesky et al. (106), who used a carotid balloon injury model and discovered both 
immediate and chronic elevation of PDGF-A transcripts and protein levels located 
preferentially on the neointimal SMCs.
Interactions between PDGF and other vasoactive peptides and growth factors have 
been studied using a variety of experimental protocols in various cell types. Stavri et al. 
(170) studied the roles of hypoxia and PDGF-B in inducing VEGF transcription in 
cultured rabbit aortic SMCs. Hypoxia alone strongly upregulated VEGF mRNA in a time- 
and concentration-dependent manner, reaching a maximum 30-fold increase after 12- 24 
hours. Exposure to PDGF-B caused only minimal increases in VEGF expression. The 
combination of hypoxia and PDGF-B administration, however, caused a synergistic 
increase in VEGF mRNA that was ~2-fold higher than the expected additive effect. These 
authors suggested that VEGF-mediated neovascularization may be mediated in part
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SMCs. Bilato et al. (17) examined the interaction between bFGF and PDGF in mediating 
rat aortic SMC migration in cell culture. Basic FGF was weakly chemoattractant for 
SMCs but was required for PDGF-stimulated SMC migration. Further analysis 
demonstrated that bFGF exerted this effect through enhancing PDGF-mediated release of 
intracellular calcium and the subsequent activation of calcium-calmodulin-dependent 
protein kinase II. PDGF-B has also been suggested to upregulate FGF tyrosine kinase 
receptor mRNA and protein (90). Thommes et al. (174) found PDGF-A and IGF-1 to be 
weakly mitogenic for cultured rat aortic SMCs; however, co-administration of these 
factors resulted in significantly increased [3H]-thymidine incorporation and a strong 
increase in SMC number. These authors proposed that the synergistic actions of PDGF-A 
and IGF-1 might be due to differential activation of their intracellular signaling pathways. 
PDGF from extracts o f human platelets has also been shown to rely on the presence of 
TGF-P 1 and EGF in stimulating anchorage-independent transformation o f neoplastic rat 
kidney fibroblasts (7). This oncogenic growth was found to depend on the presence of all 
3 growth factors. Bonner et al. (19) determined that TGF-PI causes downregulation of 
PDGF alpha receptors in fibroblasts during pulmonary fibrotic disease. These authors 
suggested that the proliferative and chemotactic influences of PDGF are dependent on the 
modulation of its receptor subtypes by other injury-induced cytokines such as TGF-P 1. 
Fibroblast Growth Factor
Basic fibroblast growth factor (bFGF) is a potent heparin-binding polypeptide 
mitogenic for vascular ECs and SMCs. Arterial and capillary ECs, SMCs, and fibroblasts 
can synthesize both aFGF and bFGF (18), while bFGF can also be produced in a wide
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variety of tissues including brain, pituitary, retina, adrenal gland, kidney, corpus luteum, 
placenta, and in various tumors (162). Basic FGF has important chemotactic and 
angiogenic properties as well as vital roles in development of the vascular, nervous, and 
skeletal systems and in cellular differentiation (90). Lindner and co-workers found SMC 
proliferation in lesions resulting from endothelial denudation in rat carotid arteries to be 
bFGF-dependent (101, 102). Basic FGF has been shown to play a role in autocrine 
growth regulation for capillary ECs (162) and in autocrine migration of cultured ECs 
(117). Sakaguchi et al. (156) determined that bFGF acts in an autocrine fashion by 
binding to cell surface receptors from the cells where the factor was originally produced. 
Basal levels of transcription for both aFGF and bFGF are low; however, both proteins 
appear at relatively high levels in many tissues (124). This may be dependent on the fact 
that bFGF does not contain a signal sequence; therefore, release of bFGF peptides occurs 
through conjugation with carrier proteins (18), sequestration by ECM constituents (11), 
or through cell lysis in vascular injury (30). Newly synthesized bFGF can be secreted and 
become associated with the basement membrane and extracellular matrix components such 
as heparan sulfate (149). Saksela et al. (158) suggested that FGF conjugation with 
extracellular glycosaminoglycan heparan sulfate protects FGF from proteolytic 
degradation. In agreement, Baird and Ling (11) in their work on cultured BAECs, 
hypothesized that the neovascular response stimulated by bFGF is more regulated by the 
presence of heparinase-like enzymes than by the actual angiogenic or mitogenic activity of 
the growth factor. However, differential responses were observed by Yu et al. (196) in 
their work on cultured BAECs. These investigators discovered that cells cultured to 
subconfluency synthesized bFGF which became localized to the nucleus and exocytotic
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vesicles, while confluent cells produced bFGF which became predominantly ECM- 
associated. Four distinct high affinity FGF receptors exist that exert tyrosine kinase 
activity and dimerize upon ligand-binding (124). FGF receptors have been identified on 
ECs, SMCs, myoblasts, and fibroblasts (18). Generally, most of these receptors have 
increased affinity for the basic form over that for the acidic form. For a thorough review 
of FGF receptors, please consult the articles by Schott and Morrow (161) or Bobik and 
Campbell (18).
Considering the angiogenic and growth-regulatory characteristics of bFGF and its 
role in mediating responses due to injury or in atherogenesis, bFGF has been proposed to 
play a role in the pathogenesis of shear stress-induced alterations. Sterpetti et al. (172) 
examined arterial SMCs exposed to varying degrees of shear stress, and found a “dose- 
dependent” release of bFGF into the medium that was still evident 24 hours after 
cessation of flow. Anti-bFGF antibody treatment verified the specificity of the mitogen, 
and results suggested shear stress stimulates SMCs to produce and release bFGF in direct 
proportion to the degree of flow in an in vitro system. Malek et al. (107) explored the 
effects of shear stress on induction of bFGF mRNA in B AECs cultured on a cone-plate 
viscometer. Steady laminar shear stress of 15 dyn/cm2 elicited a significant 1.5-fold 
increase in bFGF mRNA between 30 minutes and 6 hours, declining to baseline levels after 
9 hours. Steady laminar shear stress of 36 dyn/cm2 caused a significant increase at 30 
minutes, reached a 5-fold increase at 6 hours, and remained elevated 3-fold after 9 hours’ 
exposure. This elevated level of shear stress induced three bFGF mRNA species of 
approximate sizes 7.0, 4.0, and 1.9 kb. No differences were observed in bFGF mRNA 
expression between steady laminar and turbulent flows, or between steady laminar and
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pulsatile laminar flows. These results suggest that the dynamic characteristics of the fluid 
flow do not play as important a role as the overall magnitude of the shear stress in terms 
of stimulating bFGF gene expression.
Transforming Growth Factor
Transforming growth factor-p I (TGF-pi) is a pleiotropic factor that has been 
shown to stimulate vascular SMC hypertrophy, inhibit mitogen-stimulated DNA synthesis, 
and has been suggested to be a mediator of SMC growth in vivo during atherogenesis and 
wound repair (6, 29, 105, 135). After synthesis, TGF-pi is normally secreted from ECs, 
SMCs, and fibroblasts in a latent inactive form that is unable to bind to its cell surface 
mannose-6-phosphate/IGF II receptor (94). Certain factors such as angiotensin II, 
endothelin-l, and TGF-pi itself are capable of activating the latent form and converting it 
into a biologically active form, which may then stimulate smooth muscle growth via 
hypertrophy or hyperplasia (18, 53).
Considering its bidirectional effects on SMC growth, TGF-pi has been suspected 
as playing a role in shear stress-mediated vascular remodeling. Ohno et al. (131), 
exposing cultured BAECs to shear stress on a cone-plate viscometer, found expression of 
TGF-PI mRNA to increase directly with increases in shear stress between 0 and 40 
dyn/cm2. At constant exposure to 40 dyn/cm2, TGF-pi mRNA levels increased several 
fold within 2 hours and remained elevated at 12 hours’ exposure. These authors used a 
neutralizing TGF-31 antibody to test for biologically active mature TGF-PI, which was 
found to increase significantly in conditioned medium. With use of channel blockers, 
results indicated that the shear stress-induced increases in TGF-P1 mRNA and TGF-P1 
protein are mediated through an EC flow-activated potassium channel. In a subsequent
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study (140) these same authors further examined the mechanism of shear stress-reguiated 
TGF-P 1 gene expression. Bovine aortic ECs exposed to 20 dyn/cm2 on a cone-plate 
viscometer demonstrated a 3- to 5-fold increase in TGF-P 1 gene transcription after 
exposure to shear stress for 2 hours. Using ECs transfected with TGF-P 1 promoter-CAT 
reporter gene constructs, results indicated that shear-responsiveness of TGF-P 1 gene 
expression is mediated by shear stress-responsive cis and trans elements activated through 
flow-regulated endothelial potassium channels.
In recent work by the same laboratory on shear stress-mediated TGF-P 1 gene 
expression and protein secretion (128), cultured BAECs were subjected to varying levels 
of shear stress on a modified cone-plate viscometer. Low levels of flow (< 5 dyn/cm2) 
failed to induced significant alterations in TGF-P 1 mRNA expression; however, between 
shear stresses of 5 and 40 dyn/cm2, TGF-P 1 mRNA levels increased proportionately. In 
response to steady laminar shear stress of 20 dyn/cm2, ECs experienced a 3- to 5-fold 
increase in TGF-P 1 mRNA levels after 2 hours’ exposure, and produced a 4- to 10-fold 
increase in the amount of biologically active TGF-P 1 protein as measured in the 
conditioned medium after 24 hours’ exposure to increased flow. Using ECs transfected 
with the TGF-P 1 promoter-CAT reporter gene constructs, results indicated that the shear 
stress responsiveness of TGF-P 1 mRNA production is dependent on activation of the 
promoter region and involves transcriptional regulation. Results from channel blockade 
provided further evidence for dependency on a flow-activated endothelial potassium 
channel for increased TGF-P 1 mRNA expression. These authors speculated that the 
mechanotransduction of a shear stress stimulus through ECs leading to increases in TGF-
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3 1  involves regulation between potassium and calcium fluxes, with potassium-induced 
hyperpolarization possibly inducing calcium influx and calcium-dependent kinases and 
signaling cascades.




The general hypothesis for this research project is that elevated flow induces 
growth and remodeling of small systemic arteries in the presence o f normal arterial 
pressures under in vivo conditions. These arterial adaptations are believed to be mediated 
by several endogenous flow-induced biochemical factors. In addition, considering the 
model established herein, we expect the primary mechanical stimulus experienced by the 
local vasculature to be flow-mediated shear stress with minimal contribution from stretch- 
induced wall stress.
Specifically, we believe that elevated shear stress will stimulate arterial remodeling 
primarily in a radial direction resulting in significant luminal enlargement. We expect this 
will involve a combination of cellular hypertrophy and hyperplasia for both the endothelial 
and smooth muscle layers between 1 and 7 days. We expect a restructuring of the 
extracellular connective tissue as well as early involvement of flow-induced NO (assessed 
through eNOS expression). We hypothesize that flow-induced shear stress will stimulate 
the expression of several mechanosensitive genes. Principally, we believe that endothelial 
PDGF-B mRNA and medial PDGF-A mRNA expression will be elevated and contribute 
to enhanced endothelial and SMC proliferation. Secondarily, we believe that shear stress 
may act to regulate endothelial and/or smooth muscle bFGF mRNA and endothelial TGF- 
PI mRNA expression. We expect detection of these changes in gene expression within I 
day after onset of increased flow and persisting possibly through 3 days.
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CHAPTER IV 
RESEARCH DESIGN, MATERIALS, AND METHODS
Rat Mesenteric Flow Model
All experimental protocols in this research project complied strictly with the 
guidelines instituted by the Animal Care and Use Training Program, Eastern Virginia 
Medical School, Norfolk, VA The Animal Care Facility at EVMS is AAALAC approved 
and is directed by Thomas Sheehan, DVM. Three groups of ten male Wistar rats 
weighing approximately 300 grams each were anesthetized with Na*-pentobarbital (60 
mg/kg EM, Anpro Pharmaceutical, Arcadia, CA) and given 0.1 cc penicillin G potassium 
(10,000 units IM, Marsam Pharmaceutical, Cheny Hill, NJ). Supplemental IM injections 
of Na'-pentobarbital were provided as needed in order to maintain a surgical level of 
anesthesia. Once surgical anesthesia was obtained, the abdomens were shaved clean and 
swabbed with a topical antiseptic/antimicrobial agent (Hibiclens, Wilmington, DE). The 
rats were placed supine on a warm heating pad (~ 37°C) and covered with a sterile 
surgical drape so that only the shaved abdominal wall was exposed. Using sterile 
technique, a midline laparotomy was made spanning the length o f the abdomen from 
below the diaphragm to above the testis. The cecum, adjoining section of the small 
intestine, and supporting mesenteric membranes and vasculature were gently exteriorized 
and placed on the sterile drape. The cecum, intestines and mesentery were kept moist 
throughout the entire surgery with pre-warmed, sterile physiological saline (pH 7.4). The 
intestines and supporting vasculature were gently arranged in order to examine the fourth, 
fifth, and sixth ileal arteries (and veins) proximal to the ileocecal junction for any pre­
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existing vascular anomalies. This section of the rat mesenteric vasculature was subjected 
to altered blood flow. In addition, the ninth ileal artery (and vein) proximal to the 
ileocecal junction was examined for any abnormalities and acted as the control section for 
the rat. If pre-existing vascular anomalies were present in these regions, appropriate 
vascular sections were found between the second and eighth ileal arteries proximal to the 
ileocecal junction for the treatment group, and between the ninth and the twelfth ileal 
arteries for the control group. If  no anomalies were found, arterial ligations were made 
using sterile 10-0 Ethilon monofilament nylon suture (Ethicon, Inc., Somerville, NJ) on 
the following arteries as depicted in Figure 4-1: (1) the parent fifth ileal artery proximal to 
the ileocecal junction; (2) the second-order branch of the fourth ileal artery leading in the 
direction towards the fifth artery; and (3) the second-order branch of the sixth ileal artery 
leading in the direction towards the seventh Deal artery. In addition, any transverse 
marginal artery in the ligated arteriolar arcade that connected two second-order arterial 
branches was ligated to form a true barrier to collateral blood flow (4). Deal arteries are 
defined as pre-branching first-order parent vessels leading from the superior mesenteric 
artery to the ileum, where each divides into two second-order branches. A marginal artery 
is defined as a transverse vessel segment joining two adjacent small arterial arcades. 
Marginal and second-order arteries give rise to first-order (1 A) arterioles that directly feed 
the bowel wall.
Ligations at these specific sites allows various vessels to be subjected to four 
different scenarios: (A) high flow, normal pressure in a large ileal artery, (B) high flow, 
normal pressure in a smaller second-order artpry; (C) no flow, normal pressure in a smaller
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Figure 4-1. Rat Mesenteric Flow Model. This diagram illustrates the general 
mesenteric arterial arrangement with sites of ligation, placement of pressure cannula, and 
flow probe used for both acute hemodynamic measurements and chronic morphological 
assessments. In the chronic studies, the proximal branch o f the high flow sixth ileal artery 
was ligated. Results showed significantly increased blood flow and calculated wall shear 
rates in the high flow ileal artery and second-order branch with no significant changes in 
mean aortic or mesenteric arterial pressures. This is a paired design model with control 
and high flow vessels in the same animal. Control vessels were obtained from the ninth 
ileal artery and second-order branch proximal to the ileocecal junction and are not 
included in the illustration.
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artery; and (D) low flow, normal pressure in a smaller artery (under the possible influence 
of ischemia-induced metabolites). A fifth possible scenario involves first-order arterioles 
(l-A) of the intestinal wall located between the fourth and fifth ileal arteries proximal to 
the ileocecal junction where ischemia may occur. These sites are illustrated in Figure 4-1.
The focus of this study was on the high flow ileal artery and second-order branch 
(denoted on Fig. 4-1 as A and B, respectively) and their matching control vessels. Arterial 
ligations were made by first identifying the best site on each vessel branch for the ligation, 
and then carefully and gently clearing away surrounding adipose tissue to correctly identify 
the artery and adjacent vein. Tremendous care was taken during dissection in order not to 
stretch or injure the vessels, and unnecessary manipulation of the vessels was kept to a 
minimum. A short piece of suture was cut, gently wrapped around the artery, and tied 
twice. Because of the delicacy of this surgical technique, if the artery was punctured 
during the procedure, ligations were made directly above and below the site of damage in 
order to ensure cessation of blood loss. Once bleeding stopped, the procedure continued 
as normal. Generally speaking, the ligation around the fifth ileal artery was made first, 
followed by the ligation around the second-order branch of the fourth artery, and then the 
second-order branch of the sixth artery. During the surgery, the level of consciousness of 
the rat as well as the patency of the airway were constantly observed.
Once all ligations were complete, the number of l-A arterioles feeding the 
intestinal wall in the flow-dependent region was counted and the length (in mm) of the 
flow-dependent region measured. The flow-dependent region is considered to be the 
section of bowel receiving blood flow from the feeding sixth ileal artery (corresponding to 
section A in Fig. 4-1) proximal to the ileocecal junction. The l-A arterioles counted were
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those that spanned at least 50% of the distance across the radial bowel axis. The cecum, 
intestines, and supporting vasculature were then gently placed back into the abdominal 
cavity. The muscular abdominal wall was closed and sutured with sterile 4-0 Plain Gut 
(Ethicon, Inc.). The abdominal skin was closed using sterile surgical clips, and the area 
around the incision swabbed with an antiseptic/microbicidal solution (Pharmadine 
Solution, Sherwood Pharmaceutical Co., Mahwah, NJ). The rat was placed in a prone 
position on a separate warm heating pad with the upper thorax and head raised to aid 
breathing. Ear notches were made for identification. Detailed diagrams of the individual 
vessel arrangement and actual sites of ligation were made immediately after the surgery for 
each animal. Once fully recovered from anesthesia, rats were placed into appropriate 
cages and returned to the Animal Care Facility. Several hours after each surgery, as well 
as the next day after surgery, observations were made on each rat to ensure full recovery. 
Animals were provided water and standard rat chow ad libitum  for 1, 3, or 7 days.
After the appropriate number of days, each rat was anesthetized with Na'- 
pentobarbital (60 mg/kg, IM), and supplemental injections of Na*-pentobarbital were 
given as needed throughout the remainder of the procedure. Once a surgical level of 
anesthesia was reached, MAP was measured through tail artery cannuiation for purposes 
of establishing pressure for perfusion-fixation. The ventral portion of the tail just below 
the testis was shaved and cleaned. The animal was placed supine on a warm heating pad, 
and a midline incision was made on the proximal ventral portion of the tail to expose the 
underlying tissue and sheath covering the tail artery. The surrounding tissue was carefully 
dissected away, and the sheath opened to expose the tail artery. Two sutures were placed 
under the artery, the distal suture tied twice, and the proximal portion of the artery
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adjacent to the proximal suture clamped with micro-forceps. Lidocaine HC1 (10 mg/ml. 
Astra Pharmaceutical Products, Inc., Westborough, MA) was administered topically on 
the artery to induce dilation. Using microsurgical Castroviejo scissors, a small incision 
was made in the tail artery, and a polyethylene catheter (0.28 mm ID) inserted into the 
artery and advanced until it reaches the micro-forceps. Both proximal and distal sutures 
were tied around the catheter to secure it. The forceps were released, and a heparin 
solution (1000 units/kg BW, Elldns-Sinn, Cherry Hill, NJ) slowly injected into the artery. 
The catheter, attached to a calibrated Statham pressure transducer and a Gould Brush 
2200 recorder (Cleveland, Ohio), enabled precise and immediate recordings of tail artery 
pressure. The chart speed was set at 5 mm/sec, and a MAP was recorded once stabilized 
(approximately 5 minutes).
After a stable pressure was recorded, the rat was gently moved from the heating 
pad and placed supine in a collecting pan. A midline laparotomy was made, followed 
closely by a pneumothorax as the method for sacrifice. Since several of the internal 
organs demand large blood flows, ligation of the arteries feeding these organs allowed a 
more accurate estimate of pressure during perfusion through the thoracic aorta. The 
abdominal cavity was further opened to allow access to the internal organs. First, the left 
renal artery was ligated, followed by ligation of the left and right femoral arteries. The 
right renal artery was not ligated as the right kidney served as control for cellular 
proliferation. The inferior vena cava below the kidneys was isolated and severed to allow 
an outflow for perfiision-fixation. The thoracic aorta above the diaphragm was isolated 
and cleared of surrounding tissue. Two long sutures were placed under the thoracic aorta, 
and a small cut made in the thoracic aorta using microsurgical Castroviejo scissors. A 14
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G catheter was gently inserted into the vessel, and the catheter secured with the sutures 
and attached to a heated dual reservoir setup containing a vasodilator mixture [100 jxM 
sodium nitroprusside (Sigma, St. Louis, MO), 100 pM verapamil hydrochloride (Sigma), 
100 pM papaverine hydrochloride (Aldrich Chemical Co., Milwaukee, WI), 1 liter 0.9% 
physiological saline] and 10% buffered formalin phosphate (Fisher Scientific, Fair Lawn, 
NJ). The tubing was cleared of air bubbles, and the vasodilator mixture pumped through 
the thoracic aorta catheter and isolated mesentery and right kidney at approximate MAP 
(as recorded on the pressure transducer). After approximately 5 minutes, the system was 
switched to formalin to allow fixation of the tissues at approximate MAP. After the 
mesentery and right kidney were completely perfose-fixed, the appropriate tissues were 
carefully extracted from the rat and placed in 10% buffered formalin phosphate until ready 
for microsurgical dissection. Chart recordings o f MAP and perfusion pressure were 
appropriately labeled and saved.
Hemodynamic Parameter Measurements
In a duplicate series of experiments hemodynamic parameters were measured 
before and initially after creation of the model by arterial ligation. These measurement 
were made by our collaborator, Joseph L. Unthank, Ph.D., in the Department of Surgery, 
Indiana University School of Medicine. The left common carotid artery was cannulated in 
order to measure MAP. Following a medial laparotomy and surgical protocol as 
described above, a perivascular ultrasonic flow probe (0.5V probe and Model 206 
Flowmeter, Transonics Systems Inc., Ithaca, NY) was placed on the sixth ileal artery 
proximal to the ileocecal junction (Fig. I). The proximal second-order branch off the 
fourth ileal artery proximal to the ileocecal junction was ligated, followed by cannulation
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of the proximal branch of the sixth ileal artery proximal to the ileocecal junction. The 
cannula was oriented away from the flow-dependent region and was inserted for purposes 
of obtaining a local mesenteric arterial pressure. The cannula was constructed from 31 
gauge MicroFil tubing (World Precision Instruments, Sarasota, FL) sealed in PE 10 and 
PE 50 tubing. The fifth ileal artery proximal to the ileocecal junction was then ligated. 
The sites of arterial cannulation and ligations are included in Figure 1. Measurements of 
blood flow, arterial pressure, and internal diameters of the sixth ileal artery and its distal 
second-order branch were made prior to and after each cannulation or ligation as 
described above. Ileal artery blood flow measurements were corrected for zero offsets, 
and measurements of internal diameters were made through videomicroscopy. Before 
accepting each pressure measurement, the stopcock connecting the cannula to the pressure 
transducer was opened to the atmosphere to verify that the cannula was patent as 
demonstrated by the entrance of blood into the cannula. Finally, vessels were completely 
relaxed through topical administration of a dilator cocktail (10'4 M adenosine, 10's M 
sodium nitroprusside), with subsequent measurement of flow, pressure, and diameters. 
Wall shear rate was calculated from these data using the formula: WSR = (4Q)/(7tr3) 
where Q is blood flow (ml/sec) and r is the vessel radius (cm).
Tissue and Slide Preparation
The right kidney was cleared of surrounding adipose tissue and perirenal fascia, 
divided into three cross-sections, and fixed in formalin. The intestines and supporting 
mesenteric vasculature were closely examined under the dissection microscope 
(StereoZoom 4, Bausch & Lomb). Arteries o f interest and the section of intestinal wall 
containing one or more l-A arterioles were carefully extracted and placed in formalin.
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Control vessels and a control section o f the intestinal wall were taken from the appropriate 
location and placed in formalin.
All tissues were fixed in formalin for 4 hours, after which each was placed in a 
small section of Kimwipe paper (Kimberly-Clark Corp., Roswell, GA) and labeled. 
Keeping the tissues moist throughout this procedure, a maximum of three tissues were 
loaded per processing cassette, which was also labeled according to the tissues inside. 
The tissues were then placed in the processing unit (Autotechnicon Duo, Technicon 
Corp., Tarrytown, NY) for a 1314 hour cycle in the following baths: 70% ethanol, 95% 
ethanol, 100% ethanol, xylene, paraffin (Paraplast Plus Tissue Embedding Medium, 
Oxford Labware, St. Louis, MO). If a prolonged amount of time was expected before 
tissues were able to be processed, they were placed in the Kimwipe paper, labeled, and 
placed in 0.9% physiological buffered saline (PBS), pH 7.4, at 4 °C, until ready for 
processing.
After the tissues completed processing, they were transferred to the heating unit of 
the tissue embedding center (Tissue Tek II, Lab Tek Products, Division Miles 
Laboratories, Inc., Westmont, IL). The tissues were embedded in liquid paraffin in 
molded plastic cassettes, labeled, and allowed to solidify on the cold unit o f the embedding 
center. The tissue blocks were stored at room temperature in an ordered fashion until 
ready for use.
Tissue sections were cut from paraffin blocks at a thickness o f 4 |om using a rotary 
microtome (American Optical 820, Conneaut Lake Scientific, Conneaut Lake, PA). The 
tissue sections were placed immediately in 30% RNAse-free ethanol (30% absolute 
ethanol, 70% DEPC-H2O). Sections were transferred to a heated tttfeO bath to allow for
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adequate spreading of the tissue. Precieaned Superfrost/Plus microscope slides (Fisher 
Scientific, Pittsburgh, PA) were used for all protocols. For slides used in histologic 
staining, vessel sections were placed approximately in the middle of each slide, with only a 
single vessel type per slide. For in situ hybridization experiments, control vessels were 
placed above same animal treatment vessels on the bottom third of the slide. Also, for in 
situ hybridization experiments, duplicate slides per vessel pair were made for sense and 
antisense probes. Slides were labeled appropriately on the frosted end in pencil and stored 
in slide boxes at room temperature.
Morphological Analysis
Toluidine blue stain was prepared by adding 1 gram sodium borate and 1 gram 
toluidine blue O dye (Eastman Kodak Co., Rochester, NY) to 100 ml dH20. The was 
mixed, filtered, and stored in the dark in a light-proof container. Prepared slides were 
deparaffinized in xylene (3 min x 2) and rehydrated in 100% ethanol (10 dips x 3), 95% 
ethanol (10 dips), and dH20  (5 min) at room temperature. Slides were placed on a 37 °C 
slide warmer (Fisher Scientific) and stained with toluidine blue for 45 seconds. The slides 
were rinsed with dH20 , dehydrated in 95% ethanol (10 dips), 100% ethanol (10 dips x 3), 
and xylene (3 min x 2) at room temperature. Slides were coverslipped with Accumount 
60 mounting medium (Baxter Health Care Corp., McGraw Park, IL).
Microscopic measurement and quantitation of morphological parameters were 
performed using JAVA Video Image Analysis Software System (Jandel Scientific, Jandel 
Corp.) linked to a Zeiss 25 binocular microscope (Carl Zeiss, Oberkocken, W. Germany). 
Pixel gray level thresholds were set for optimum contrast, and inside and outside
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circumferences were automatically traced and digitized. Data transformations provided 
values for lumen area, wall area, and inside and outside diameters.
Immunocvtochemistrv Protocols
Proliferating Cell Nuclear Antigen
The protocol used for immunocytochemical localization of PCNA is modified from 
that of Vector Laboratories (Vector Laboratories, Inc., Burlingame, CA) for use with 
paraffin-embedded formalin-fixed tissues. Two slides per sample were used, one positive 
and one negative control. Prior to starting the protocol, tissue sections were outlined 
using a diamond pencil, and the slides were labeled according to the primary antibody used 
(or negative control). Except for the initial incubation step or unless otherwise specified, 
all reactions took place at room temperature.
Slides were incubated in a 55 °C oven for I hour or until the paraffin was 
completely dissolved. Tissues were deparaffinized and rehydrated in xylene (4 min x 3), 
100% ethanol (2 min x 3), 95% ethanol (2 min x 2), 70% ethanol (2 min), and CIH2O (5 
min). Endogenous peroxidase activity was blocked with 0.4% hydrogen peroxide in 
methanol for 10 minutes. Slides were washed in PBS for 20 minutes, followed by a 20 
minute treatment in a humidified chamber with 5% normal goat serum (Vector 
Laboratories) as a blocking agent. The positive slides were treated with the primary 
antibody mouse monoclonal anti-PCNA clone PC-10 (Boehringer Mannheim Corp., 
Indianapolis, IN) in a 1:200 dilution with PBS in a humidified chamber for 2 hours. 
Negative slides received 5% normal goat serum only, and positive and negative slides 
were kept in separate chambers. Slides were then washed with PBS for 20 minutes. All 
slides received the secondary antibody biotinylated goat anti-mouse IgG (Vector Labs) in
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a 1:400 dilution with PBS in a humidified chamber for 30 minutes. Slides were washed in 
PBS, and treated with Vectastain Elite Avidin-Biotinylated Complex immunoperoxidase 
system (Vector Laboratories) for 30 minutes. Slides were rinsed in PBS and incubated in 
a diaminobenzidine tetrahydrochloride (DAB, Sigma) chromagen solution for 5 minutes in 
a humidified chamber. The DAB solution contained 0.1 M imidazole, 0.2% DAB, 
hydrogen peroxide, and PBS. Slides were washed under running tap water for 5 minutes, 
followed by counterstaining with hematoxylin (Gill’s Formulation #1, Fisher Scientific) for 
5 minutes. Slides were again washed under running tap water for 5 minutes, dehydrated 
and cleared in the following washes: 70% ethanol (2 min), 95% ethanol (2 min x 2), 100% 
ethanol (2 min x 2), and xylene (2 min x 2). Slides were air dried and coverslipped with 
Accumount 60 Mounting Medium (Baxter Health Care Corp.). Unless otherwise 
specified, all treatments took place at room temperature.
Endothelial Nitric Oxide Svnthase
The ICC protocol for eNOS is similar to that described above for PCNA but with 
several exceptions. The endogenous peroxidase blocking step with hydrogen peroxide 
was extended to 30 minutes instead of 10 minutes, followed by a 20 minute wash in PBS. 
The tissues were then permeabilized with a 20 minute wash in 0.15% Triton X-100 
(Sigma) in PBS, followed again by a 20 minute PBS wash. Blocking serum (5% NGS) 
was added as stated above for PCNA. The primary antibody was a mouse affinity-purified 
monoclonal IgG-1 against eNOS (Transduction Laboratories, Lexington, KY) used in a 
1:1000 dilution. The immunospecificity of this monoclonal antibody has been validated 
through both Western blot and preadsorption immunohistochemistry (195). Primary 
antibody incubation proceeded overnight at 4 °C in a sealed humidified chamber. The next
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day slides were washed briefly with PBS and treated to the secondary antibody 
(Biotinylated Goat Anti-Mouse IgG) in a 1:200 dilution for 30 minutes. The procedure 
then proceeded as described above.
Analysis o f positive and negative tissues and quantitation of ICC results were 
performed through direct microscopic measurement (Zeiss 25 binocular microscope; Carl 
Zeiss) and by utilizing the JAVA  Video Image Analysis Software System (Jandel 
Scientific). For PCNA slides, the total number of medial SMC nuclei, as well as the 
number of PCNA-positive and negative SMC nuclei, were systematically counted. For 
analysis of ECs, the absolute number of intimal EC nuclei were counted. These nuclear 
counts were subsequently normalized to wall area and luminal perimeter, respectively. For 
eNOS analysis, slides were blindly scored according to a 0 - 4 grading scale for positive 
stain specific to the endothelial luminal lining. A score of 0 denoted negative staining 
while a score of 4 indicated excellent specific stain.
Extracellular Connective Tissue Staining
Tissue cross-sections were stained for extracellular connective tissue using a 
modification of the protocol included in Masson’s Trichrome Stain kit (Sigma). Slides 
were deparaffinized and rehydrated in xylene (3 min x 2), 100% ethanol (2 min x 2), 95% 
ethanol (2 min x 2), 70% ethanol (2 min), and CIH2O (5 min). Tissues were treated with 
Bouin’s histological reagent solution (Sigma) for 15 minutes at 56 °C as a general fixative 
and to intensify the final coloration step. Slides were washed under running tap H20  for 
several minutes and treated with the nuclear stain hematoxylin (Gill’s #1 formulation, 
Fisher Scientific) for 5 minutes. After a short dH20  rinse, slides were treated with 
Biebrich-Scarlet acid fuschin solution for 2 minutes to stain muscle fibers and cytoplasm.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
52
Slides were rinsed in (tffcO and treated with a phosphotungstic-phosphomolybdic acid 
solution for 5 minutes, followed by collagen staining in aniline blue solution for 8 minutes. 
Coloration was intensified through exposure to a 1% acetic acid solution for 2 minutes, 
and the slides were dehydrated and cleared in the following washes: 70% ethanol (2 min), 
95% ethanol (2 min x 2), 100% ethanol (2 min x 2), and xylene (2 min x 2). Slides were 
air dried and coverslipped with Accumount 60 Mounting Medium (Baxter Health Care 
Corp.). Unless otherwise specified, all reagents were included in the kit (Sigma) and all 
treatments took place at room temperature. Microscopic evaluation o f these slides was 
performed using the video image analysis system Image-1 (Universal Imaging 
Corporation, West Chester, PA) linked to a Sony DXC-151 CCD camera (Sony, Japan) 
and Nikon Optiphot-2 microscope (Nikon, Japan). Quantitation of percent connective 
tissue in vessel medial wall cross-sections was achieved using established stereologic 
methods (56). Quantitative stereology provides an efficient and unbiased method for 
directly estimating the areal fraction of profiles (in this study the stained connective tissue) 
in a standardized area of a structure (the medial wall) through the use o f a fixed test grid 
system (56). 
cDNA Subcloning
The following is a general description of cDNA subcloning techniques that were 
used for preparing linearized DNA used in synthesizing 3SS-CTP labeled riboprobes. 
Details are then given concerning subcloning specifications for the following factors: 
PDGF-A, PDGF-B, bFGF, and TGF-P 1.
For consistency purposes, and to allow use of standard RNA polymerases T3 and 
T7, all cDNAs were subcloned into pBluescript SK+ (Stratagene, La Jolla, CA) if
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originally located in a different plasmid. If in a plasmid other than pSK+, the cDNA was 
cut out of the original plasmid using appropriate restriction endonucleases and buffers, and 
the fragment ligated into an appropriate site in pSK+ using DNA ligase. The DNA 
fragment in pSK+ was used to transform XL 1-Blue cells (Stratagene) which were plated 
on LB-ampicillin agar plates and grown overnight. Appropriate clones with cDNA inserts 
were picked according to the integrity of the 0 -galactosidase gene and blue/white color 
detection. The cDNA was amplified and purified using Qiagen Plasmid purification 
systems (Qiagen Inc., Chatsworth, CA). Appropriate linearized sense and anti-sense 
strands were constructed using restriction endonuclease digestion. The linearized DNA 
strands were diluted to 0.5 pg/pl and stored at -20 °C in TE buffer, pH 8.0, until ready for 
riboprobe synthesis. Throughout this process, PC/Gene Software was utilized for 
verifying restriction sites with restriction maps, and 1% agarose gel electrophoresis used 
to verify the efficiency of cutting, proper fragment lengths, and orientation of the 
fragment.
PPGF-A:
The genomic sequence for PDGF-A chain was identified by Collins and co­
workers (20). The cDNA for PDGF-A was available in our laboratory as a pBluescript 
SK+ insert in a Sal I/Sac II site. Sal I and T3 make a 368 bp sense strand, and Sty I and 
T7 make a 321 bp antisense strand.
PDGF-B:
The original genomic sequence was identified by Aaronson and co-workers (143). 
In our laboratory, the PDGF-B cDNA was initially cut out of pUC-13 and oriented into a 
Xba I/Sma I site in pBluescript SK+. The original length was 272 bp; however, Xba I did
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not give complete digestion when trying to linearize the DNA. An alternate Bst XI site 
was found that provided proper cutting, but gave 3’-overhangs. Treatment of this 
antisense chain with DNA polymerase I Klenow fragment prior to probe synthesis 
provided blunt ends through exo- and endonuclease activity (another possibility for 
antisense chain linearization is to use Not I which leaves acceptable 5’ overhangs). The 
final length o f both sense and antisense chains was 265 bp. Sma I and T3 make sense 
while Bst XI and Klenow fragment (or Not I) and T7 make antisense.
bFGF:
The original nucleotide sequence of bFGF was identified by Abraham et al. (1). In 
our laboratory, the cDNA for bFGF was available in pSK+ in an Eco RV site. The 704 bp 
segment was linearized with Xho I and T3 to make sense and Bam HI and T7 to make 
antisense.
TGF-B1:
The original cDNA sequence was desribed by Qian et al. (138). In our laboratory, 
the cDNA was available in pBluescript II KS+ as a 985 bp fragment in a Sma I/Bam HI 
site. The restriction sites between the promoters are reversed in pKS+ when compared to 
the pSK+ positions. Treatment with Eco RI (or Sma I) and T7 make sense, while Bam HI 
and T3 make antisense.
3sS-CTP Riboprobe Synthesis
All enzymes and buffers for 3SS-CTP riboprobe syntheses were purchased from 
Promega Corporation (Madison, WI). Linearized sense and anti-sense cDNA strands 
were transcribed in the presence of 90 pCi 35S-CTP (Dupont de Nemours, Boston, MA) in 
a standard 20 pi transcription reaction containing transcription buffer (5x), 100 mM DTT.
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RNAse inhibitor, ATP, UTP, CTP, GTP, I pg linearized cDNA and the appropriate RNA 
polymerase T3 or T7. If a 3’ overhang existed on the cDNA, it was treated with DNA 
polymerase I Klenow fragment (5 units/pg DNA) for 15 minutes at room temperature. 
Transcription proceeded for 2 hours at 37 °C, and the reaction stopped with DNAse. 
Radionucleotide incorporation was measured using PEI cellulose-F chromatography paper 
(EM Industries, Inc., Gibbstown, NJ) and phosphorimager analysis (Molecular Dynamics). 
The samples were then purified on a Sephadex G-50 spin column (5 Prime —> 3 Prime, 
Inc., Boulder, CO). The DNA was eluted, treated with 10 mg/ml tRNA and 100 mM 
DTT, and if probe length exceeded 800 bp, subjected to limited alkaline hydrolysis for a 
final length of 150 bp. Alkaline hydrolysis consisted of incubation at 60 °C in 0.2 M 
Na2C03 and 0.2 M NaHC03 for a calculated amount of time. The time for alkaline 
hydrolysis was determined according to the following calculation: initial length of probe 
(in kb) - 0.15 kb 0.11 kb-min'1 x initial length of probe x 0.15 kb. Small volume aliquots 
were prepared, the pH was neutralized, and the probe precipitated in cold 100% ethanol 
(2.5 x volume) and 3 M NaOAc, pH 7.5 and stored at -70 °C until use. On the day of use, 
an aliquot was centrifuged, the supernatant removed, and the pellet treated with cold 70% 
ethanol for 5 minutes. The solution was centrifuged again and the supernatant removed. 
The probe pellet was dried down and resuspended in 20 mM DTT and formamide. Prior 
to use for in situ hybridization, a 1 pi sample of the probe was added to 6 ml scintillation 
cocktail in order to measure radioactivity (desired results 106 CPM/pl).
In situ Hybridization
The in situ hybridization methods used in this laboratory are primarily based on 
those described by Wilcox (191) for formalin-fixed, paraffin-embedded tissues. All
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equipment used on day 1 of this protocol was treated with either 3% hydrogen peroxide 
or 0.5M NaOH to destroy RNAse enzyme. Also, all solutions made for day 1 were 
prepared with RNAse-free materials and diethyl pyrocarbonate (DEPC; Sigma) treated 
dH20. Slides were cleared and deparaffinized in xylene and graded alcohols. The slides 
were washed in 0.5 x SSC for 10 minutes, deproteinated with a 5 pg/ml solution of 
proteinase K tritirachium album (Amresco, Solon, Ohio) for 10 minutes at room 
temperature, and rinsed 3 times in PBS. The slides were post-fixed in 4% 
paraformaldehyde (Sigma) for 10 minutes at 4 °C, and rinsed 3 times in PBS. The were 
then covered with 200 |xl prehybridization stock containing 50% dextran sulfate, 50x 
Denhardt's solution, EDTA, Tris, NaCl, DEPC-H2O, and formamide in a humidity 
chamber for 2 hours at approximately 40 °C. The prehybridization solution was allowed 
to drip off, and the tissues were incubated with 100 |il hybridization solution containing 1 
M DTT, 10 mg/ml yeast tRNA, and radioactive probe at 106 CPM/slide in the humidity 
chamber (Isotemp Incubator, Fisher Scientific) at 55 °C overnight.
Solutions and equipment used on day 2 of this protocol were not RNAse-free. 
The slides were removed from the incubator after the hybridization step and washed in a 
low stringency solution o f 2 x SSC and 10 mM fi-ME-EDTA for 20 minutes. Slides were 
treated to a 40 pg/ml RNAse A solution (Sigma) for 30 minutes at room temperature to 
digest unhybridized probe. Slides were washed again in the low stringency solution for 20 
minutes, followed by four 1 hour washes in a high stringency solution of 0.1 x SSC and 10 
mM 3-ME/l mM EDTA at 55 °C. Slides were rinsed in 0.5 x SSC for 20 minutes, and 
then serially dehydrated in graded alcohols containing 0.1 x SSC and 1 mM DTT. Slides 
were allowed to air dry overnight.
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Emulsion. Developing, and Counterstaining
Kodak NTB-2 emulsion (Eastman Kodak Co.) was heated at 42 °C for several 
hours prior to dipping. All slides were placed inverted in specially designed slide holders. 
In absolute darkness, emulsion was gently mixed with an equal amount of warmed dH20  
and poured into a glass slide holder immersed in a pre-heated H20  bath. Slides were 
dipped into the emulsion mixture for approximately 1 second, removed and placed 
inverted in an incubator box containing dessicant. After all slides were dipped, the box 
was sealed shut and the slides allowed to air dry overnight. The next day, in absolute 
darkness, slides were transferred to individual black boxes (containing dessicant), which 
were wrapped in aluminum foil, labeled, and stored in a separate incubator box at 4 °C for 
10 weeks.
After the appropriate amount of time, the slides were brought to room 
temperature. Kodak Dektol Developer (Eastman Kodak Co.) was prepared (17 g. 
developer to 250 ml dH20  at 32 - 38 °C) and diluted with an equal amount of dH20 . 
Kodak Fixer (Eastman Kodak Co.) was also prepared (45 g. fixer to 250 ml dH20). In 
absolute darkness, slides were removed from the black boxes and placed in slide holders. 
Slides were dipped in developer for 4 minutes, dH20  for 30 seconds, and fixer for 5 
minutes, after which they were placed in room temperature dH20  until all slides were 
completed. Slides were washed under slowly-running tap water for 15 minutes and 
allowed to air dry overnight.
The next day slides were cleared in xylene and rehydrated in graded alcohols. 
Slides were counterstained in hematoxylin dye (Surgipath Harris Formula, Surgical 
Medical Laboratories, Inc., Richmond, IL) for 2 minutes, followed by a 2% glacial acetic
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acid rinse for 30 seconds. Slides were soaked in dH20  and treated with a bluing agent 
(sodium bicarbonate, lithium carbonate in dH20 ) for 30 seconds. Slides were soaked in 
dH20, 95% ethanol, and treated with eosin-y stain (Surgipath, Surgical Medical 
Laboratories, Inc.) for 1 minute. Slides were dehydrated, cleared, air dried, and 
coverslipped with Accumount 60 Mounting Medium (Baxter Health Care Corp.).
Microscopic evaluation o f in situ hybridization slides was performed using the 
Image-1 system linked to a Sony DXC-151 CCD camera and Nikon Optiphot-2 
microscope. Pixel threshold intensity gray levels were set, and secondary filters were 
established to cover a narrow range of silver grain size. A region of interest was made 
covering approximately 50 pm2. Automatic silver grain counts were performed in both the 
endothelial and medial layers in vessel cross-sections. Data from duplicate samples were 
averaged, and mean values for sense were subtracted from those for anti-sense to provide 
an overall value for specific signal. Data were represented as number of grains per 50 pm2 
of tissue for wall area measurement, and as number of grains per 15 pm luminal perimeter 
for endothelial measurements.
Statistical Analysis
Data were stored and analyzed on personal computers using Instat 2 (Graphpad 
Software, v. 2.02), Excel (Microsoft, v. 5.0), and Sigma Plot (Jandel Scientific, v. 2.0). 
Morphological data were analyzed using a two-way ANOVA with post-hoc Bonferroni- 
corrected paired and unpaired T-tests. This two-way ANOVA allows analyses of 
between- (time) and within- (treatment) subjects and considers interaction effects. Flow, 
WSR, and pressure data were analyzed using a repeated measures one-way ANOVA (a 
two-way ANOVA without replication) with post-hoc Bonferroni and Student-Newman-
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Keuls tests. Subjective eNOS scores were analyzed using the non-parametric Wilcoxon 
signed rank test for data from non-Gaussian populations. All other data were analyzed 
using a two-tailed paired Student’s T-test. All data, means and variances were tested for 
normality using ANOVA-associated Normality tests. Unless otherwise specified, data 
were presented as mean values ± SEM, and the null hypothesis was rejected at an 
uncorrected a  level of 0.05. Paul Kolm, PhJD., and members of the Lewis Hall computer 
center were available for consultation.
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CHAPTER V
RAT MESENTERIC FLOW MODEL INDUCES SIGNIFICANT INCREASES 
IN SHEAR STRESS WITH POSSIBLE CONTRIBUTION FROM
WALL STRESS
Introduction
Vascular homeostasis is continuously influenced by the mechanical forces created 
by transmural pressure and blood flow. Arterial pressure is directly related to 
circumferential wall stress and affects primarily medial and adventitial components of the 
vessel wall. Blood flow exerts tangential shear stress acting predominantly on the luminal 
aspect of intimal ECs. This shear stress can also affect underlying SMCs through 
interstitial fluid flow (3, 4, 188). These biophysical forces have been implicated in the 
pathophysiology of various vascular disorders such as localization of atherosclerotic foci 
and formation of intimal, subintimal, and medial neoplasias. A primary concern in studies 
of the pathophysiology o f hemodynamic stimuli is the inability to completely separate the 
influence of wall stress from that of shear stress. Even when transmural pressure is held 
constant, the influence of flow-induced vasodilation leading to increased wall stress 
through cell stretch warrants consideration. The aim of the experiments in this chapter 
was to characterize a unique rat mesenteric flow model in order to differentiate the roles 
of wall stress and shear stress in mediating vascular remodeling under in vivo conditions.
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Results
Control and post-ligation hemodynamic parameter data are summarized in Table 5- 
1. Eight rats were successfully evaluated for this part of the study. Neither mean arterial 
(carotid artery) nor local mesenteric pressures changed significantly post-ligation. Prior to 
any ligations, ileal artery blood flow averaged 65 ± 0.08 ml/min. After ligation of only the 
proximal branch off the sixth ileal artery, ileal artery blood flow decreased 35 ± 5% (data 
not shown). For control conditions before any ligations, it was assumed that flow through 
the second-order branch artery was equal to half of the flow through the parent ileal 
artery. This assumption seems reasonable considering that the in vivo inner diameters of 
the two branches were similar under control conditions (220 ± 18 pm distal vs. 213 ± 13 
pm proximal branch). After ligation of the proximal branch, the flow through the ileal 
artery and the only remaining branch would be equal. Given this assumption, after ligation 
of the proximal second-order branch of the sixth ileal artery and ligation of the adjacent 
fifth ileal artery, blood flows through the supplying ileal artery and distal branch were 
increased 36 ± 13% (p < 0.01) and 170 ± 25% (p < 0.001), respectively, relative to pre­
ligation control conditions. Significant flow-induced dilation was demonstrated in the ileal 
artery (~7%; p < 0.001), while the second-order artery did not experience a significant 
increase (-5%) in internal diameter post-ligation. The ileal artery exhibited a 
nonsignificant (-10%) increase in calculated average WSR, while average WSR in the 
second-order branch increased 118 ± 27% (p < 0.001). Measurements of completely 
dilated vessels indicate that control ileal arteries possess ~6% tone while control second- 
order arteries have -9%  tone under resting conditions (data not shown).
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Parameter: Control Post-ligation
MAP (mm Hg) 111.8 ±4.3 (8) 119.4 ±3.4  (8)
Second-order branch pressure (mm Hg) 91.0 ±2.6 (6) 88.3 ± 5.7 (6)
Ileal artery blood flow (ml/min) 0.65 ±0.08 (8) 0.83 ±0.07(8)**
Second-order branch blood flow (ml/min) 0.33 ±0.04 (8) 0.84 ±0.07 (8)***
Internal radius (|om): ileal artery 150.3 ±6.3 (8) 160.7 ± 7.3 (7)***
Internal radius (tun): second-order branch 130.2 ±8.9 (7) 136.8 ±6.0  (7)
WSR (sec'1): ileal artery 4125 ±468 (8) 4545 ±630 (8)
WSR (sec*1): second-order branch 3832 ± 647 (7) 7618 ± 1193 (7)***
Data represent control and post-ligation mean ± standard error o f the mean for 
arterial pressure, blood flow, vessel internal radius, and calculated wall shear rate (WSR): 
[(4Q)/(7rr3) where Q = blood flow (ml/sec) and r = vessel radius (cm)]. Sample size is 
indicated in parentheses. Data were analyzed using a repeated measures ANOVA with a 
post-hoc Student-Newman-Keuls test and an a  = 0.05. ** p < 0.01; *** p < 0.001 
versus pre-ligation values.
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Discussion
This chapter attempts to characterize a modification of an existing mesenteric 
collateral flow model established by Unthank et al. (181) that utilizes a series o f arterial 
ligations (Fig. 4-1) which force a supplying ileal artery to feed the arterial arcade and 
bowel in the flow-dependent section. Upon setting the ligations, blood flow through the 
feeding ileal artery and its second-order branch increased significantly (Table 5-1). Acute 
flow-induced dilation exhibited in the ileal artery (~7%) offset any significant increase in 
calculated WSR for this vessel. The second-order artery, however, did not significantly 
dilate resulting in a highly significant doubling of its calculated WSR. Considering the 
acute flow-induced dilation experienced by the high flow ileal and second-order branches 
(+7%; +5.4%, respectively) and the acute changes observed in WSR in these vessels 
(+10%; +100%, respectively), we believe the primary stimulus for both ileal and branch 
vessels is shear stress; moreover, the ileal artery may be exposed to acute flow-induced 
cell stretch and its associated wall stress which may contribute to the remodeling 
evidenced in this vessel. After administration of a vasodilator cocktail, the ileal artery 
demonstrated -6% tone while the second-order branch possessed -9%  tone under control 
conditions. Based on measurements of wall area, the assumption o f conservation of wall 
area during active dilation, and surgical manipulation perhaps injuring the response, we 
believe that the maximum change in acute wall stress that could have occurred in these 
vessels would be -10%. This may be an adequate stimulus to induce acute arterial 
remodeling in these vessels. Co-existence of these flow-induced stresses and their 
combined influence on local vasculature accurately portrays normal conditions
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experienced by blood vessels in vivo. As discussed in Chapter 6, chronic wall stress 
appears to remain stable (as measured through wall thicknessilumen diameter ratios), 
suggesting that flow-induced stresses are temporally normalized by vascular adaptations 
involving luminal enlargement and wall hypertrophy.
A primary concern in developing this model was abolition of any influence of 
altered arterial pressure, since pressure-induced wall tension alone can stimulate an array 
of biochemical and molecular signals (33, 118, 146). In addition, the influence of 
pressure-induced myogenic tone contributing to alterations in wall stress must be 
considered. In this model, neither mean carotid nor local mesenteric arterial pressures 
changed significantly post-ligation (Table 5-1). In a recent paper by Unthank et al. (181), 
3 to 4 sequential ileal arteries were ligated creating a region containing 44-55 1A 
arterioles subject to collateral flow through the two boundary ileal arteries. Collateral 
blood flow increased approximately 274% through the supplying ileal arteries; however, 
local mesenteric pressure at the center of the collateral-dependent region decreased 
approximately 53%. A reduction in the passive diameters of both arteries and arterioles 
from the decrease in pressure at this location could alter wall stress and shear stress and 
potentially influence their growth response. The model used in the current study allows 
specific examination of flow-induced stresses without the influence of pressure-mediated 
stimuli.
This model allows high flow and control arteries for both ileal and second-order 
branches to be studied in the same animal. This greatly reduces the individual variation 
inherent when using different animals for control and treatment groups. Standardization
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of the exact site for vessels to be ligated, as well as the sites to obtain unligated control 
vessels, also decreases individual variation. In addition, for purposes of maintaining 
consistency, diagrams of the mesenteric artery arrangement were made during the 
surgeries for each rat. The length of the collateral flow-dependent region was measured 
and the number of 1A arterioles feeding the intestinal wall in the region was counted. 
The practicality of performing the surgeries to establish this model also offers several 
advantages. Through the use of Na^-pentobarbital (60 mg/kg IM) as our choice of 
anesthetic, rats generally achieve a surgical level of anesthesia within 30 minutes, maintain 
this level of anesthesia for the duration of the surgery (approximately 45 minutes), and 
recover completely after an additional 1 to 2 hours. Only on rare occasion was 
supplemental anesthetic given during the surgeries. After performing the medial 
laparotomy, the cecum and adjacent ileum were easily identified and exteriorized. 
Through the use of a dissecting microscope, the overall architecture of the mesenteric 
vasculature was easily visualized and the exact location for setting the ligations was easily 
and rapidly determined. Separating the artery from its adjacent vein proved troublesome, 
but by using a curved suture needle ligating only the artery was made easier. These 
various factors specific to this model help establish it as a unique and useful experimental 
tool that can be used to address hemodynamic forces and their effects on vascular 
physiology under in vivo conditions.
In conclusion, this chapter details a novel experimental model that allows 
manipulation of hemodynamic parameters under in vivo normotensive conditions. The 
primary stimulus for the ileal and second-order arteries was determined to be flow-induced 
shear stress, with possible contribution from stretch-induced wall stress for the larger
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vessel. Considering the arterial remodeling discussed in the following chapters, this rat 
mesenteric flow model permits an exclusive flow stimulus leading to significant in vivo 
growth regulation in small mesenteric arteries and allows continued analyses of possible 
signaling factors involved.
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CHAPTER VI
FLOW INDUCES ARTERIAL LUMINAL ENLARGEMENT AND MEDIAL 
WALL HYPERTROPHY THROUGH ENDOTHELIAL AND SMOOTH MUSCLE 
NUCLEAR REPLICATION AND CELLULAR HYPERPLASIA
Introduction
Arterial remodeling from hemodynamic stresses has been demonstrated using 
various experimental preparations on a variety of cell types. Unthank and co-workers 
showed elevated collateral flow stimulates luminal enlargement (179) and medial wall 
hypertrophy (181) in rat small mesenteric arteries. Langille and co-workers found blood 
flow directly regulates developmental proliferation of cellular and extracellular vessel wall 
constituents in young rabbits (91) in addition to stimulating remodeling of the vessel wall 
in adult rabbits (92, 186). In contrast, Kraiss et al. (86) showed SMC proliferation to be 
inversely correlated with shear stress using polytetrafluoroethylene graft implants in 
baboons. Other models of experimental atherogenesis (197), in situ perfused organ 
culture (13), and arteriovenous shunts (111) have revealed differential results concerning 
the influence of hemodynamic stresses on arterial wall restructuring. In terms of cellular 
mechanisms behind structural remodeling of the arterial wall associated with changes in 
lumen diameter, EC and SMC hyperplasia and/or cellular hypertrophy, reorganization of 
existing wall components, cellular migration, alterations in ECM constituents, cell death 
and removal, or combinations of all of these may be involved.
As discussed in the previous chapter, the primary stimulus in the experimental 
model presented here is flow-induced shear stress with possible contribution of acute wall
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stress in the ileal artery. The aim of the experiments in this current chapter was to 
characterize the remodeling response o f small mesenteric arteries exposed to elevated 
blood flow in vivo. Flow-induced arterial remodeling in terms of luminal enlargement and 
medial wall hypertrophy was analyzed for both treatment and time effects over a 7 day 
period. The endothelial and smooth muscle cellular mechanisms contributing to these 
gross morphological alterations were examined through immunocytochemical approaches 
and nuclear profile analyses.
Results
Rat Mesenteric Flow Model
Thirty rats were successfully analyzed for this part of the experiment. During 
establishment of the arterial ligations according to the mesenteric flow model (Figure 4-1), 
several parameters were measured for purposes of maintaining consistency throughout the 
experiment. The mean length of the flow-dependent region, defined as the section of the 
intestinal wall subject to blood flow from the unligated ileal artery, was 41.83 ± 0.88 mm. 
The number of 1A arterioles that fed the intestinal wall in the flow-dependent region was 
19.3 ± 0.67, while the MAP (measured for purposes of setting individual pressures for 
perfusion-fixation) was 89.3 ± 1.52 mm Hg.
Morphological Analysis
Figures 6-1 and 6-2 graphically illustrate flow-induced alterations in inside lumen 
diameter and medial wall area, respectively, for ileal and second-order arteries after 1,3. 
and 7 days of increased blood flow. The 2-way ANOVA shows there is no significant 
interaction (p = 0.11) between flow and duration o f exposure for changes in ileal artery 
lumen diameter. Significant increases in lumen diameters were observed in both control (p
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< 0.002) and high flow (p < 0.005) ileal arteries with time. Post-hoc Bonferroni-adjusted 
statistics indicated a significant increase (+13%) in lumen diameter for ileal arteries 
exposed to high flow for 7 days when compared to same animal control vessels. The 2- 
way ANOVA demonstrated a significant (p = 0.004) interaction between flow and the 
duration of exposure for changes in lumen diameter in the second-order arteries. Lumen 
diameters for control second-order arteries did not change significantly with time. Post- 
hoc independent comparisons revealed +14% and +38% increases in lumen diameter for 
high-flow second-order vessels when compared to same animal controls after exposure to 
flow for 3 and 7 days, respectively. The 2-way ANOVA for flow-induced changes in 
medial wall area (Fig. 6-2) suggested significant interactions between flow and time exist 
for both the ileal artery (p = 0.014) and the second-order artery (p = 0.005). Post-hoc 
analysis indicated that after 7 days of increased flow, ileal artery wall area was significantly 
(+58%) elevated compared to its same animal control. Similarly, post-hoc analyses 
showed that high flow second-order arteries exhibited significant medial wall area 
enlargement compared to corresponding control vessels after 3 (+53%) and 7 (+120%) 
days of elevated flow. Medial wall areas for control ileal and second-order arteries did not 
change significantly with time.
Figure 6-3 compares the sensitivity of the ileal artery to that of the smaller second- 
order branch in terms of flow-induced changes in inside diameter and medial wall area (as 
a percent change compared to relative control vessels). These data clearly show a
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Figure 6-1. Flow-Induced Alterations in Lumen Diameter. Flow-induced alterations in 
lumen diameter for ileal and second-order vessels show no interaction between high flow 
and time for ileal artery luminal enlargement, with both control and treatment vessels 
experiencing significant increases with time. Significant interactions between flow and time 
were demonstrated for the second-order artery lumen diameter. Post-hoc independent 
comparisons of control versus treatment for each time point are indicated. Data were 
evaluated with a 2-way ANOVA using post-hoc Bonferroni-corrected T-tests. Values 
represent mean ± SEM, and n = 10 for each group. * p < 0.05, ** p < 0.01, *** p < 
0.001 versus control; 'S’ p < 0.05, tir,cuJ p < 0.01 versus day.
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Figure 6-2. Flow-Induced Alterations in Medial Wall Area. Flow-induced alterations 
in medial wall area for ileal and second-order vessels. Significant interactions between 
flow and time were demonstrated for changes in ileal and second-order artery wall area. 
Post-hoc independent comparisons o f control versus treatment for each time point are 
indicated. Data were evaluated with a 2-way ANOVA using post-hoc Bonferroni- 
corrected T-tests. Values represent mean ± SEM, and n = 10 for each group. * p < 0.05, 
** p < 0.01, *** p < 0.001 versus control; p < 0.05, 'fr'fi’ p < 0.01 versus day.
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Figure 6-3. Percent Change in Lumen Diameter and Medial Wall Area. The
percent change in lumen diameter and medial wall area between control and high flow 
vessels suggest a “dose-dependency” in terms of the magnitude of the flow-induced 
response. The percent changes in medial wall area far exceed those evidenced for luminal 
expansion in both vessels in response to flow. Values represent mean ± SEM, and n = 10 
for each group. * p < 0.05.
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significantly heightened response for the second-order artery compared to the larger ileal 
artery for flow-induced alterations after 7 days in both lumen diameter and wall area. 
Figure 6-3 also indicates that the relative increases in medial wall area far exceed the 
changes observed in inside diameter after exposure to elevated flow. Figures 6-4 and 6-5 
respectively illustrate medial wall thickness.lumen diameter ratios and medial wall 
arearlumen area ratios. No significant differences were detected for high flow vessels 
compared to same animal control vessels at any time.
ICC Results fo r PCNA/SMC Nuclear Profile Analysis
In order to determine the ratio of medial SMCs undergoing active DNA replication 
and cell division, ICC was performed for PCNA and medial SMC nuclei were counted. 
Figure 6-6 illustrates the percent PCNA-positive medial SMC nuclei for high flow vessels 
divided by those for control vessels. Data were best represented in this fashion to account 
for elevated basal PCNA counts, which averaged between 7% and 21% in both ileal and 
branch arteries. These data clearly indicate ileal artery medial SMCs undergo significant 
DNA synthesis after 3 and 7 days of elevated blood flow (+189%, +179% compared to 
same animal controls, respectively), while significant DNA synthesis occurs in the second- 
order arterial branch after 7 days (+407% compared to control).
In the case of polyploidy whereby cells undergo DNA replication without cell 
division, cells can stain positive for PCNA without a change in cell number (14). Figure 
6-7 shows absolute medial nuclear counts with significant SMC hyperplasia indicated in
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Figure 6-4. Medial Wall Thickness:Lumen Diameter Ratio. Medial wall 
thicknessrlumen diameter ratios for ileal and second-order arteries show no significant 
differences between high flow and control vessels. These data show that similar increases 
are observed in wall thickness when compared to luminal expansion, indicating that 
chronic wall stress is stabilized in the presence of normal arterial pressure. Values 
represent mean ± SEM, and n = 10 for each group.
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Figure 6-5. Medial Wall Area to Lumen Area Ratio. Medial wall area:lumen area 
ratios for ileal and second-order arteries show no significant differences between high 
flow and control vessels. These data show that similar increases are observed in medial 
wall hypertrophy when compared to luminal area and indicate that chronic wall stress is 
stabilized in the presence of normal arterial pressure. Values represent mean ± SEM, and 
n = 10 for each group.
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Figure 6-6. Medial Wall SMC PCNA Ratio. Immunocytochemical results for medial 
SMC PCNA in ileal and second-order arteries. Data represent percent PCNA-positive 
medial SMC nuclei for high flow vessels divided by those for control vessels for both the 
ileal artery and second-order branch. Data suggest significant DNAsynthesis in the media 
of SMCs after exposure to elevated flow for 3 and 7 days. Values represent mean ± 
SEM, and n = 6 for each group. * p < 0.05, ** p < 0.01 versus control.
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Figure 6-7. Absolute Medial Wall SMC Nuclear Counts. This data indicate 
significantly increased cell division after in vivo exposure to flow for 7 days for both ileal 
and second-order arteries. Significant differences in absolute nuclei number were not 
detected between control and high flow vessels after 1 or 3 days. Values represent mean 
± SEM, with n = 6 for each group. * p < 0.05 versus control.






























Figure 6-8. Normalized Medial Wall SMC Nuclear Counts. This data suggest that, 
at almost all time points, increased cell division is proportional to increased medial wall 
area to maintain a constant SMC density. The second-order vessel demonstrates a 
significant decrease in cell density upon exposure to elevated flow after 7 days, 
suggesting that cellular hypertrophy and perhaps nuclear polyploidy may be involved in 
this vessel at this time point. Alternatively, SMCs in this vessel may be actively engaged 
in the cell cycle prior to cytokinesis. Values represent mean ± SEM, with n = 6 for each 
group. * p < 0.05 versus control.
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both high flow ileal (+30%; p < 0.04) and second-order (+73%; p < 0.05) arteries after 7 
days. When data were normalized to medial wall area (Fig.6-8), SMC nuclear density 
remains constant in the presence o f enlarged wall areas for almost all time points in both 
the ileal and second-order arteries. However, data indicate that the second-order artery 
experienced significant SMC hypertrophy after exposure to elevated flow for 7 days, as 
shown by a decreased (-22%; p < 0.02) medial nuclear density concomitant with an 
increased wall area. These results imply that flow-mediated vessel wall remodeling in vivo 
occurs primarily through SMC hyperplasia with some contribution of cellular hypertrophy 
in small branching mesenteric arteries. Additionally, the second-order branch may be 
experiencing nuclear polyploidy after exposure to flow for 7 days, as suggested by 
increased nuclear replication in the presence of a decreased nuclear (and cellular) density.
EC Nuclear Profile Analysis
Figures 6-9 and 6-10 illustrate absolute and normalized intimal EC nuclear counts, 
respectively. At 1, 3, and 7 days of increased flow, absolute EC nuclear counts were 
significantly elevated in both the ileal (+17%, +50%, +65%; respectively) and second- 
order (+33%, +89%, +81%; respectively) arteries when compared to same animal control 
vessels. When data were normalized to 100 pm luminal perimeter, only in the I day 
second-order vessels did the increase in EC counts not reach significance (p = 0.07). 
Percent changes for normalized data for the ileal and second-order artery at 1, 3, and 7 
days were +17%, +38%, and +44%, and +23%, +67%, and +36%, respectively. These 
results suggest that after 24 hours o f increased blood flow in vivo, rat mesenteric arterial 
ECs are stimulated to undergo significant cellular replication leading to increased EC
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Figure 6-9. Absolute Intimal EC Nuclear Counts. These results indicate that once 
blood flow is increased, flow-mediated stresses are rapidly sensed by intimal endothelium 
leading to EC replication after 24 hours continuing through 7 days. Values represent 
mean ± SEM, with n = 10 for the ileal artery group and n = 8 for the second-order branch 
group. * p < 0.05, *** p < 0.001, **** p < 0.0001 versus control.
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6-10. Normalized Intimal EC Nuclear Counts. These data represent intimal EC 
nuclear counts normalized to 100 pm luminal perimeter. The flow-mediated stress 
stimulus is rapidly sensed by the endothelium, leading to significant EC replication in the 
ileal artery after 24 hours, and in the second-order vessel after 3 days. Values represent 
mean ± SEM, with n = 10 for the ileal artery group and n = 8 for the second-order branch 
group. * p < 0.05, *** p < 0.001, **** p < 0.0001 versus control.
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densities. This exaggerated EC hyperplasia persists through 7 days of increased flow. 
Discussion
In this model, significant adaptations occurred in terms of luminal enlargement and 
medial wall hypertrophy in the ileal and second-order arteries after exposure to elevated 
flow (Figs. 6-1, 6-2). Generally, these morphological alterations were dependent upon the 
duration of in vivo flow exposure between I and 7 days. Deal artery lumen diameters of 
both control and high flow vessels increased significantly with time. This implies that 
significant developmental growth in terms of luminal enlargement may be occurring in 
normal -10 week old rat mesenteric ileal arteries over a 7 day period. Considering the 
significant interactions between day and treatment for all other morphological data, 
however, the authors believe that age was not a major factor influencing the results of this 
study. In agreement, Unthank et al. (180) found minimal bowel growth occurs in normal 
Wistar-Kyoto rats from 10 to 20 weeks of age.
Several important points should be mentioned when analyzing these flow-induced 
morphological data. A heightened adaptive response of the smaller second-order artery is 
noticed when compared to that of the larger ileal artery (Fig. 6-3). Percent changes in 
lumen diameter of high flow ileal arteries compared to same animal controls range 
between 1% and 13%, while the same changes for the second-order vessels range between 
10% and 38%. Similarly, percent changes in medial wall area of high flow ileal arteries 
compared to same animal controls range between -9% and 58%, while the same changes 
for the second-order vessels range between 18% and 120%. Considering that the increase 
in blood flow and calculated WSR were significantly higher in the smaller second-order
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branch compared to the parent ileal artery, the degree of flow-mediated vascular 
remodeling is suggested to be dependent on the magnitude of the flow stimulus in 
mesenteric vasculature. Another important observation concerns the greater changes 
observed in medial wall area compared to those found in luminal diameter. This suggests 
that a more dramatic adaptive response occurs affecting the circumferential component as 
opposed to the radial component o f the vessel wall, supporting a role for wall stress in 
mediating these events. This is somewhat counter-intuitive, considering that the normal 
adaptation to increased blood flow is luminal enlargement to restore shear stress towards 
normal. In this model, highly significant increases in wall area, more consistent with 
changes in transmural pressure or wall stress, occur in the presence of unaltered arterial 
pressures. These results support a role for wall stress in addition to shear stress in 
contributing to flow-induced vascular remodeling. However, these results also raise 
questions concerning the signal transduction pathways that might be stimulated from 
increased blood flow in vivo. A possible role for flow-regulated growth factors in 
mediating in vivo vascular growth is addressed in the subsequent chapters.
The flow-mediated growth alterations evidenced in this study are structural rather 
than functional, because all vessels were maximally relaxed when formalin-fixed. This 
represents forms of vascular remodeling, as proposed by Langille and O’Donnell (92) in 
their work with rabbit common carotid arteries. These authors found a 21% decrease in 
lumen diameters in arteries subject to 70% flow reduction after 2 weeks. Based on the 
results that papaverine did not attenuate the response, they suggested that the decreased 
lumen diameters were the result of chronic flow-dependent structural modifications
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occurring in the arterial wall. Results from the current study indicate that structural 
modifications from increased flow occur rapidly in the arterial wall and become 
statistically significant after exposure to elevated flow for 3 days.
Through a derivation of the Laplace relation for wall tension, if arterial pressure is 
held constant, a stable wall thickness:lumen diameter ratio implies a normal wall stress. In 
the current model, a constant wall thickness: diameter ratio between I and 7 days (Fig. 6- 
4) suggests that long-term wall stress remains constant. Luminal enlargement with medial 
wall hypertrophy coincident with a normal wall thicknessidiameter ratio has been found by 
several other investigators using models of experimental atherogenesis in monkey iliac 
arteries (197) and collateral flow in rat mesenteric (179) and rabbit basilar arteries (96). In 
addition, a stable medial wall area.lumen area (Fig. 6-5) is shown for both vessels at all 
time points, indicating that the relative increases in wall area are similar to those for 
luminal enlargement. However, Price and Skalak (147) used a computational arteriolar 
network model based on a rat spinotrapezius transverse arteriole-collecting venule arcade 
and suggested wall stress to be a primary determinant for arteriolar remodeling and 
terminal arteriolar growth. Computed arteriolar shear stresses did not correlate with 
arteriolar remodeling in their model, but increased capillary shear stress did stimulate 
formation of arterio-venous shunts. The relative contributions o f shear stress versus flow- 
stimulated wall stress in regulating vascular growth and remodeling in arterioles and small 
arteries necessitates further studies. Based on the assumptions and results from the 
current study as discussed in Chapter S, we believe the primary stimulus for these vessels 
is shear stress with possible influence of acute flow-dependent wall stress in the ileal
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artery. These flow-induced forces, then, can stimulate arterial remodeling as evidenced in 
this study.
Analysis o f SMC and EC nuclei can provide insight into the cellular mechanisms 
governing structural remodeling of the arterial wall. Immunocytochemical results for 
PCNA (Fig. 6-6), a cell cycle-dependent cyclin (112), suggest ileal and second-order 
branch medial SMCs undergo DNA replication after 3 days of in vivo exposure to 
increased shear stress. Polyploid ceils with DNA replication in the absence of cytokinesis, 
however, can erroneously be counted positive according to PCNA data (14). Absolute 
medial wall SMC nuclear counts (Fig. 6-7) suggest cellular hyperplasia after 7 days of 
elevated flow in both the ileal and second-order arteries. These combined data imply that 
elevated flow stimulates DNA replication and cellular division in medial SMCs under in 
vivo conditions. Normal SMC nuclear densities for the ileal and second-order arteries 
(Fig. 6-8) indicate that as medial wall hypertrophy occurs in response to elevated flow, 
SMC hyperplasia maintains a constant SMC density. After exposure to high flow for 7 
days, however, the second-order artery exhibited a slightly significant (p = 0.046) decrease 
in SMC density. Medial wall hypertrophy in this vessel at this time point may involve a 
combination of cellular hypertrophy and hyperplasia. Considering the PCNA data, nuclear 
polyploidy may be involved also. This would be in agreement with the findings of Owens 
(134) that large vessel SMC hypertrophy is often accompanied by development of nuclear 
polyploidy in hypertensive animals. Owens suggested that polyploidy may act as a gene 
amplification adaptive mechanism commensurate with an increased transcriptional 
requirement of an enlarged cell. Another interpretation of the data for this vessel at this
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time point is that numerous SMCs may be actively engaged in the cell cycle prior to 
cytokinesis. Once the remodeling process becomes complete, cellular hyperplasia and 
diploidy would result.
These results characterizing medial wall growth in response to increased blood 
flow are in concordance with the results from previous studies on developing animals. 
Langille et al. (91) found significant decreases in lumen diameter and arterial wall mass 
with significantly decreased DNA levels in flow-restricted carotid arteries in juvenile 
rabbits. Wang and Prewitt (187) established a unique unilateral orchidectomy model in 
developing rats and analyzed microvascular cremaster arterioles during normal or reduced 
blood flow. After 3 weeks of flow reduction due to a decreased demand, lumen diameters 
and cross-sectional wall areas were significantly reduced when compared to the arterioles 
of the control contralateral cremaster. In recent work by Unthank et al. (179) on 
collateral flow in rat mesenteric arteries, medial SMC hypertrophy was indicated after 1 
week and SMC hyperplasia after 4 weeks contributing to medial wall expansion during 
luminal enlargement. In contrast to these findings, Sterpetti et al. (171) found an inverse 
relation between SMC growth rate and the magnitude of shear stress between 0 and 9 
dyn/cm2 in cultured bovine aortic SMCs. In addition, DNA synthesis was significantly 
reduced after 24 hours exposure to all levels of shear. However, direct exposure of the 
underlying SMCs to shear stress is not a factor in the current study. Kraiss et al. (86), 
through the use of vascular prostheses implanted in baboons, elicited a doubling of aortic 
blood flow with a resulting decrease in neointimal cross-sectional area, SMC proliferation, 
and total SMC volume. The authors noted, however, that by using rigid prosthetic aortic 
grafts, shear stress-induced vasoactive agents could not influence vessel diameter as would
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normally occur in an in vivo situation. Lumen diameter, therefore, was altered only 
through changes in neointimal thickness which implies flow-mediated wall stress as the 
primary stimulus.
In the current study, intimal ECs were found to be rapidly and significantly 
affected by exposure to increased blood flow as shown by dramatic EC hyperplasia after 
24 hours (Fig. 6-9). This may be part of an adaptive process coincident with increasing 
lumen diameters to maintain a stable EC density along the lumen perimeter, however, 
normalized EC counts in the high flow vessels indicate a dramatic endothelial replication 
leading to increased EC densities in all vessels at almost all time points (Fig. 6-10). These 
results are consistent with the results o f Unthank et al (179), who found the number of EC 
nuclei in high flow collateral vessels -90% greater than those observed in control vessels 
after both 1 and 4 weeks. Walpola et al. (186) discovered a 33% decrease in EC number 
in ligated rabbit carotid arteries after 5 days exposure to an -80% decrease in blood flow. 
Masuda et al. ( I l l )  found EC density significantly elevated in high flow canine carotid 
arteries after 4 weeks; however, a corresponding increase in lumen diameter was not 
detected. The results from these studies, along with the present work, illustrate a 
significant direct influence of blood flow and shear stress on intimal EC replication. 
However, several investigators (28, 99, 119, 200) have found an inverse relation exists 
between blood flow and EC division in cultured aortic ECs. In cell culture, however, flow 
and shear stress stimulate a phenotypic change from a proliferative cell to a differentiated 
cell. In addition, cultured cells are usually not pre-conditioned to flow, as is the case with 
an in vivo preparation. Under culture conditions, the influence of growth factors is 
dramatically increased compared to the in vivo environment (104). These variables must
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be considered and caution used when comparing results between in vivo and in vitro 
experiments.
In conclusion, the experiments described in this chapter examined the influence of 
flow-associated stresses on arterial remodeling in an in vivo experimental model. 
Significant luminal expansion and medial wall hypertrophy occurred in a time-dependent 
fashion over a 7 day period in both ileal and second-order branching arteries. These 
adaptations involved early and dramatic EC hyperplasia after 24 hours with subsequent 
medial SMC DNA replication and cellular hyperplasia after 3 days.
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CHAPTER VII
INCREASES IN EXTRACELLULAR CONNECTIVE TISSUE CONTRIBUTE 
TO FLOW-INDUCED VESSEL WALL HYPERTROPHY
Introduction
Results from the previous chapters demonstrated that significant luminal 
enlargement and medial wall hypertrophy occurred in arteries exposed to flow-mediated 
stresses between 1 and 7 days. Further examination revealed EC and SMC nuclear and 
cellular replication as mechanisms contributing to the gross morphological changes 
observed. In order to completely analyze flow-mediated alterations in the medial wall, the 
contribution of extracellular connective tissue components must be considered. Most 
work in this area has focused on the endothelium and the ECM of its basement membrane. 
Ookawa et al. (133) determined that cultured aortic ECs were dependent upon the 
presence of underlying ECM components type IV collagen, heparan sulfate, chondroitin 
sulfate, and dermatan sulfate for shear stress-induced cytoskeletal rearrangement. Wilson 
et al. (194) found strain-stimulated DNA synthesis in cultured SMCs was dependent on 
the composition of the underlying matrix. Cyclical strain increased DNA synthesis in cells 
grown on collagen I, fibronectin, and vitronectin, but did not affect cells grown on elastin 
or laminin. In addition, the responses to strain were dependent on the interactions 
between and Ovfis integrins and the specific matrix proteins. The extracellular 
components fibronectin, laminin, collagen type IV, and vitronectin have been found to 
redistribute in terms of fibril orientation and thickness (175, 176, 189) and to both increase 
and decrease in response to shear stress (57, 132, 175, 176) and cyclic stretch (173). The
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aim of the present chapter is to characterize alterations in extracellular connective tissue of 
the vessel wall after exposure to elevated blood flow and to determine its contribution to 
flow-induced vessel wall hypertrophy under in vivo conditions.
Results
Figure 7-1 shows the percent extracellular connective tissue present in the medial 
vessel wall for control and high flow ileal and second-order arteries. No significant 
differences were observed between control and high flow vessels at any time. The percent 
of medial wall occupied by extracellular connective tissue in control arteries ranged from 
29% to 34%, while in the high flow arteries ranged from 34% to 41%. These results 
indicate that as the vessel wall hypertrophied in response to elevated flow, a concomitant 
increase in medial extracellular connective tissue occurred. Figure 7-2 shows 
photomicrographs of trichrome-stained extracellular connective tissues for same animal 
control and high flow vessels. The photo for the 7 day control animal contains a grid used 
for stereologic assessment.
Discussion
The vessel medial wall is comprised of both cellular and extracellular components. 
As discussed in Chapter 6, exposure to elevated blood flow stimulated DNA replication 
and cellular hyperplasia in medial SMCs, thus contributing to significant medial wall 
hypertrophy. As the medial wall remodeled in response to elevated flow, synthesis of 
medial extracellular connective tissue was stimulated resulting in a constant percent 
connective tissue in the medial wall at all times (Fig. 7-1). This increase in connective





























Figure 7-1. Percent Extracellular Connective Tissue in Medial Wall. A stable 
percent extracellular connective tissue in the medial wall indicates that as the medial wall 
hypertrophies, increased synthesis of medial connective tissue occurs to maintain a normal 
medial wall environment. Values represent mean ± SEM, and n = 8 for each group.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Control High flow
92
Figure 7-2. Photomicrographs of Trichrome-Stained Extracellular Connective 
Tissue.
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tissue acts to maintain normal cell-cell contact concomitant with an enlarged wall area. If 
the extracellular components do not increase coincident with an enlarged wall area, 
disruption of the local micro-environment could occur. Physiologic roles for these ECM 
components include regulating EC adhesion, cellular spreading and migration, protein 
synthesis and EC proliferation, and cellular differentiation (reviewed in 175). Alterations 
in extracellular anatomy concomitant with altered SMC replication is essential for proper 
maintenance of vascular homogeneity and regulation of vascular physiology. In addition, 
upregulation of various growth factors can directly influence the proliferation of 
extracellular components. Ross (154) determined that PDGF can stimulate synthesis of 
ECM components under in vitro conditions. The findings of Sankar et al. (159) and 
Roberts et al. (150) established a role for TGF-Pl in inducing in vitro fibronectin 
expression and collagen formation, respectively. Ignotz and Massague (71) found TGF- 
Pl to increase expression of both fibronectin and collagen and to increase their 
incorporation into the surrounding ECM. In the current study, TGF-PI transcription was 
not altered by elevated flow; however, elevated levels of PDGF-A mRNA were detected 
in the high flow ileal artery after 24 hours (Fig. 9-1). This increase in PDGF-A could 
possibly enhance synthesis o f extracellular connective tissue as observed in this study.
One important role that has been proposed for the ECM is that it can act as an 
extracellular store for various growth factors. Kelly et al. (80) found that the alternatively 
spliced long-form of PDGF-A produced by cultured CHO cells was primarily localized to 
the underlying matrix, the short-form of PDGF-A predominantly secreted, and PDGF-B 
distributed between cells, ECM, and cell supernatant. Subsequent work by the same 
laboratory (41) found that plasmin released a mitogenically-active form of PDGF from
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underlying ECM in a variety of cell types. The ECM has also been identified as a storage 
site for other growth factors including TGF-P and bFGF (21, reviewed in 41). Basic FGF 
peptide has been found to localize to ECM-associated heparan sulfate proteoglycans, 
where it can be released through the actions o f plastnin (157). This raises the possibility of 
shear stress inducing EC-derived plasminogen activators and inhibitors, which could then 
enzymatically release bFGF from the ECM through plasmin formation. Diamond et al. 
(40) found TPA secretion to be significantly increased over control levels in cultured 
HUVECs exposed to arterial levels of shear stress. In addition, release of these factors 
from the ECM often occurs in a regulated fashion and may be mediated by specific 
extracellular proteases such as chondroitin lyase (80) in addition to plasmin (22). This 
ability of the ECM to sequester growth factors is pertinent to the present study, as our 
results show upregulation of PDGF-A chain mRNA in SMCs and ECs surrounded by 
extracellular connective tissue. Even if transcription of a certain factor is increased and 
elevated protein levels result, physiologic activity may be significantly influenced by 
storage in the ECM.
In conclusion, this chapter illustrates that as the medial wall hypertrophies in 
response to elevated flow and its associated stresses in vivo, a concomitant increase in 
extracellular connective tissue synthesis occurs to maintain normal vessel architecture. 
This increase in ECM tissue could be directly stimulated by increased flow or, more likely, 
involves stimulation from local action of flow-induced growth factors.
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CHAPTER VTII 
ENDOTHELIAL-DERIVED NITRIC OXIDE MAY MEDIATE FLOW- 
INDUCED VASCULAR REMODELING
Introduction
The ability of NO to mediate numerous aspects vascular function has been well 
substantiated. Flow-induced increases in NO transcription, translation and release have 
been demonstrated by numerous investigators using in vitro, in vivo, and isolated intact 
vessel preparations (27, 28, 88, 103, 130, 169). The feedback mechanism of NO- 
dependent vasoactive relaxation in response to elevated blood flow acts to influence 
arterial tone and regulate blood supply to downstream tissues. Shear stress regulation of 
the endothelial isoform of NOS has been investigated at the transcript (126, 177) and 
protein (126, 142) levels. In addition, the influence of cyclic strain on eNOS mRNA, 
protein translation, release, and activity has been studied (9, 10). The aim of this current 
chapter is to determine the influence o f flow-associated stresses on arterial eNOS levels in 
our in vivo rat mesenteric flow model and to characterize the possible role of NO in 
mediating flow-induced arterial remodeling.
Results
Immunocytochemical results for eNOS in control and high flow vessels are 
depicted in Figure 8-1. Blind scoring o f the specific eNOS signal was performed using a 0 
- 4 grading scale, and scores were assessed using appropriate non-parametric statistics. 
Data show significantly elevated eNOS scores in the high flow ileal artery at all time 
points. After 1,3, and 7 days of elevated flow, eNOS scores were increased 49%, 55%,
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and 70%, respectively, in the high flow ileal arteries compared to controls. Only after 7 
days of elevated flow did the eNOS scores reach significance for the second-order vessels 
(+69%; p < 0.05). Endothelial NOS scores for 1 and 3-day high flow second-order 
vessels were still elevated over controls (+28%, +24%, respectively), although statistical 
significance was not reached. Photomicrographs of eNOS-immunostained cross sections 
are shown in Figure 8-2 with same animal control and high flow vessels.
Discussion
The role of NO in mediating many aspects o f vascular homeostasis is well 
documented (24, 42, 82, 178). The importance of NO in regulating vascular tone in the 
mesenteric circulation has also been characterized by several investigators (48, 68, 73). In 
addition, flow-dependent alterations in NO transcription and translation have been 
elucidated using a variety of experimental conditions (23, 62, 87, 88, 177); however, 
studies analyzing shear stress regulation of eNOS are somewhat limited. Shear stress- 
induced increases in eNOS mRNA, protein, and release have been documented in cultured 
BAECs and HUVECs (126, 127, 136, 142). In addition, cyclic strain has been found to 
upregulate eNOS mRNA and protein expression in cultured BAECs (9, 10). However, 
the influence of shear stress on eNOS upregulation under in vivo conditions has yet to be 
substantiated.
Results from the current study suggest that eNOS protein was elevated in arteries 
exposed to increased blood flow after 24 hours (Fig. 8-1). As discussed in Chapter 5, 
the influence of flow-mediated wall stress in these vessels was lower than that of shear 
stress. These results are consistent with previous studies demonstrating
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Figure 8-1. Endothelial NOS Protein Levels. Immunocytochemical results for eNOS 
in control and high flow vessels indicate significantly elevated peptide levels in the ileal 
artery after 1, 3, and 7 days of elevated flow, and significantly elevated levels in the 
second-order artery after 7 days. Blind scoring of the specific eNOS signal was 
performed using a 0-4 grading scale, and statistical analysis was performed using a paired 
replicate Wilcoxon signed rank test. Values represent mean ±  SEM, with n = 10 for the 
ileal artery group and n = 7 for the second-order artery group.





Figure 8-2. Photomicrographs of ICC Slides for eNOS.
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that flow upregulates eNOS protein levels in cultured ECs (126, 142). Several 
investigators have found eNOS-mediated NO to be anti-mitogenic and inhibitory for DNA 
synthesis in vascular SMCs (51, 52, 122). Our results showing increased eNOS protein 
concomitant with early EC hyperplasia and luminal enlargement and medial wall 
hypertrophy after 3 and 7 days, then, seem rather counter-intuitive. However, several 
investigators have recently found that NO mediates the mitogenic effects of VEGF on 
cultured micro vascular venular ECs (120) and amplifies bFGF-induced mitogenesis in 
primary rat aortic SMCs (61). In addition, Ziche et al. (198) found that the NO- 
generating agents SNP, ISDN, and GTN stimulated DNA synthesis in cultured ECs 
isolated from coronary postcapillary venules. Results from treatment o f cells with L- 
NMMA and methylene blue suggested endogenous NO can directly modulate EC 
proliferation in the microvasculature. Subsequent work from the same laboratory (199) 
demonstrated that substance P-induced angiogenesis in vivo in rabbit cornea and in vitro 
in ECs isolated from coronary postcapillary venules were both potentiated by 
administration of SNP, ISDN, and GTN. Nitric oxide donation was found to significantly 
enhance EC thymidine incorporation, cell number, and migration in vitro. Leibovich et al. 
(97) determined that LPS-stimulated human monocyte-induced angiogenesis required an 
L-arginine/NOS-dependent effector mechanism, as assessed in vivo in rat corneas and in 
vitro by chemotaxis of HUVECs. Indeed, the results cited here, as well as those from the 
present study, identify crucial roles for NO in mediating various vascular mechanisms 
including cell migration and chemotaxis, cellular proliferation and nuclear replication, 
angiogenesis, and synergism and potentiation with other vasoactive agents.
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In conclusion, this chapter suggests NO as a possible signaling factor in flow - 
mediated vascular wall remodeling under in vivo conditions. Elevated eNOS levels 24 
hours through 7 days after initiation of the flow stimulus imply that NO, probably in 
combination with cytokines or growth factors, is involved in the cellular changes leading 
to flow-induced luminal enlargement and/or medial wall hypertrophy.
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CHAPTER IX
EARLY MEDIAL AND SUBSEQUENT ENDOTHELIAL PLATELET-DERIVED 
GROWTH FACTOR-A CHAIN MAY BE INVOLVED IN FLOW-MEDIATED 
VASCULAR REMODELING IN VIVO
Introduction
Platelet-derived growth factor is an important regulator of the vasculature that 
influences cell migration, proliferation, chemotaxis, angiogenesis, cell-cell adhesion, and 
cellular metabolism (1SS). PDGF exists as both the homo-dimers -AA and -BB or as the 
heterodimer -AB. Upon binding to and dimerization of the receptor, PDGF can stimulate 
vasoconstriction, mitogenesis, chemotaxis, and other functions in a variety of cells (153, 
155). Various mechanical perturbations including shear stress have been found to 
stimulate transcription (64, 65, 66, 115), translation (85), and release (30) of the -AA 
homodimer in both endothelial and smooth muscle layers. Shear stress-mediated PDGF-A 
induction and subsequent migration and proliferation of SMCs and fibroblasts 
corroborates with the “response to injury hypothesis of atherogenesis” proposed by Ross 
(154). Increased shear stress may be sensed as an insult by the endothelial and smooth 
muscle layers, which can respond by synthesizing and secreting growth factors 
contributing to atherogenesis and formation of intimal and medial neoplasias. As 
discussed in previous chapters, the experimental model employed in the current study 
induces an increase in in vivo blood flow leading to EC and SMC hyperplasia and vessel 
wall remodeling. The aim of this and subsequent chapters is to determine the role of
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various biochemical growth factors in this flow-mediated vascular remodeling. 
Specifically, this chapter examines PDGF-A mRNA expression in control and high flow 
vessels using m situ hybridization approaches.
Results
In situ hybridization data for medial wall SMC PDGF-A mRNA expression are 
illustrated in Figure 9-1. A highly significant (+215%) increase in medial PDGF-A mRNA 
is indicated for the high flow ileal artery after 24 hours. This increase becomes non­
significant after 3 (+122%) and 7 (+42%) days as the values decline towards control 
levels. An elevated basal expression of medial PDGF-A mRNA in the ileal artery remains 
constant with time. No significant differences between control and high flow vessels were 
detected for the second-order artery at any time. Figure 9-2 shows in situ hybridization 
data for endothelial PDGF-A mRNA expression. The ileal artery shows a non-significant 
(+39%) increase in EC levels after 24 hours which becomes significant after 3 (+129%) 
and 7 (+182%) days. No significant differences were detected between control and high 
flow second-order arteries; however, data for this vessel were somewhat noisy and 
resulted in irregular control values. Figure 9-3 contains autoradiographs for PDGF-A 
mRNA expression for same animal sense and anti-sense control and high flow vessels. 
Discussion
The most obvious result from this chapter is the highly significant upregulation of 
ileal artery medial PDGF-A expression after exposure to increased blood flow for 24 
hours (Fig. 9-1). According to the results discussed in previous chapters, once the flow 
stimulus was established in this model, significant EC hyperplasia occurred after 24
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Figure 9 - I. Medial SMC PDGF-A mRNA Expression. Medial wall SMC PDGF-A 
mRNA expression for control and high flow ileal and second-order branch vessels after in 
situ hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 
10 weeks. PDGF-A mRNA expression is significantly elevated in the ileal artery after 24 
hours, and then gradually declines towards normal levels by 3 and 7 days. Basal levels of 
PDGF-A mRNA expression are evident in the control ileal artery. No significant 
differences were detected between control and high flow second-order arteries, and 
control level of expression in these vessels was low. Values represent mean ± SEM, and 
n = 9 for the ileal artery group and n = 7 for the second-order artery group.
































Figure 9-2. Endothelial PDGF-A mRNA Expression. Endothelial PDGF-A mRNA 
expression for control and high flow ileal and second-order branch vessels after in situ 
hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 10 
weeks. PDGF-A mRNA expression is significantly elevated in the ileal artery endothelium 
after exposure to high flow for 3 and 7 days. No significant differences were detected 
between control and high flow second-order arteries, with specific signal similar to 
background levels. Values represent mean ± SEM, and n = 10 for the ileal artery group 
and n = 7 for the second-order artery group.
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Figure 9-3. Autoradiographs for PDGF-A mRNA Expression.
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hours with subsequent SMC hyperplasia and luminal and medial wall remodeling after 3 
and 7 days. The significant upregulation of PDGF-A mRNA in the ileal artery media after 
24 hours strongly suggests its involvement in flow-mediated vascular remodeling. 
Autocrine growth stimulation by PDGF has been characterized by several investigators 
(115, 154, 185). Indeed, autocrine mitogenicity from PDGF-A seems to be involved in 
the current model, as early medial expression precedes subsequent medial SMC DNA 
synthesis, cellular hyperplasia, and medial wall hypertrophy. An opposing proposal was 
offered by Vlodavsky et al. (184), who suggested that PDGF exerts its mitogenic action in 
a paracrine mechanism to affect neighboring cells within the vessel wall. In the current 
model, perhaps elevated medial PDGF-A is stimulating neighboring ECs to multiply. 
Although not specifically analyzed in this study, medial PDGF-A protein levels are most 
likely elevated after 3 and 7 days of elevated flow. Results showing no significant 
differences between control and high flow second-order branches are somewhat confusing, 
although heterogeneity in vascular growth responses between different orders of vessels as 
well as between components of a single vessel has been characterized by Daemen and De 
May (32) and Bobik and Campbell (18).
Basal levels of PDGF-A mRNA expression are evident in this study for the ileal 
artery media. This would corroborate the findings of Majesky and coworkers (104, 106) 
who found PDGF-A mRNA constitutively expressed in quiescent normal newborn and 
adult rat aortic and carotid artery SMCs. In addition, Majesky et al. (106) found basal 
levels of transcripts for PDGF receptor subunits, indicating that the normal vessel wall has 
the potential to synthesize and respond to both basal and increased levels o f PDGF.
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Endothelial PDGF-A mRNA expression was detected preferentially in the high 
flow ileal artery after 3 and 7 days (Fig. 9-2). This result is interesting considering that 
rapid EC replication occurred after 24 hours (Figs. 6-10, 6-11). If  the flow-mediated 
stress stimulus was sensed immediately by the endothelium and transferred to subjacent 
medial SMCs through cell-cell contacts (matrix proteins, focal adhesion sites), then medial 
expression of PDGF-A could occur after 24 hours as shown. Then, through an autocrine 
positive feedback loop (154), endothelial expression could subsequently be stimulated by 3 
and 7 days resulting in EC hyperplasia. Alternatively, this delayed increase in EC PDGF- 
A transcription could indicate repair of a shear stress-injured endothelium, as suggested by 
Majesky et al. (106) who showed increased SMC PDGF-A mRNA 2 weeks after arterial 
balloon injury. However, this does not account for the relatively small increase (+39%) in 
EC PDGF-A mRNA observed after 24 hours. Perhaps the cellular machinery involved in 
initially sensing the stimulus and starting the signaling cascade leading to nuclear 
transcription was delayed, as the percentage of PDGF-A mRNA steadily increases at 3 
and 7 days.
PDGF-A may act through an autocrine mechanism to induce synthesis of medial 
ECM evidenced in this study (Chapter 7). Ross (154) suggested that growth factors 
induce synthesis of underlying extracellular connective tissue components in vitro. The 
ECM is capable of regulating storage and release of growth factor peptides (referenced in 
41); therefore, enhanced expression of medial PDGF-A evidenced in this study could 
reasonably translate into elevated protein levels, followed by sequestration in the ECM 
and subsequent autocrine stimulation of cellular and extracellular factors.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
108
An early catalyst for SMCs to proliferate when exposed to an injuring stimulus 
involves increased PDGF-A transcription, as determined by Majesky et al. (106) using a 
rat carotid balloon catheter injury model. PDGF-A mRNA levels were elevated 10- to 12- 
fold 6 hours after balloon injury in carotid SMCs. This transient increase in SMC PDGF- 
A mRNA directly preceded entry into the synthetic phase of the cell cycle. Interestingly, 2 
weeks after wounding neointimal SMCs expressed elevated PDGF-A transcripts and 
protein levels while expression in subjacent SMCs had returned to normal. This suggests 
that PDGF-A plays dual roles in response to arterial injury: first, an immediate 
upregulation occurs in order to mediate chemotaxis and cellular and extracellular 
proliferation directly in response to the injury, and second, a chronic elevation of PDGF-A 
occurs as part of the regeneration process and arterial repair.
In conclusion, early medial and subsequent endothelial expression of PDGF-A 
mRNA in ileal arteries exposed to flow-associated stresses in vivo may contribute to the 
cellular replication and vessel wall remodeling observed in this study. Temporal and 
autocrine regulation o f this growth factor is implied, as significant medial expression after 
24 hours contributed to subsequent endothelial expression after 3 and 7 days. Basal 
transcription of PDGF-A was observed in the media o f the ileal artery, supporting the 
findings of previous investigators. However, characterizing the in vivo regulation o f this 
growth factor, in terms of shear stress responsiveness and interaction with other factors, 
cytokines, and extracellular components, necessitates further examination.
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CHAPTER X
PLATELET-DERIVED GROWTH FACTOR-B CHAIN IS NOT INVOLVED IN 
FLOW-INDUCED VASCULAR REMODELING
Introduction
The physiologic actions of PDGF in the vasculature are well established. 
Expression of the PDGF-B chain has been associated with medial SMC proliferation and 
migration leading to intimal thickening (74), chemotaxis and vasoconstriction (124), and 
stimulation of other growth-regulatory genes and mesenchymal cells producing 
extracellular components (18). In normal arteries, a low level of basal expression exists 
for PDGF-B in the media with higher levels found in the endothelium (192). The influence 
of physiologic stresses such as vascular injury and repair (81, 106), cyclic strain (193) and 
shear stress (66, 107, 118, 147) can significantly alter PDGF-B transcription and 
translation. Shear stress upregulation o f PDGF-B mRNA has been shown in cultured ECs 
from several sources (64, 66, 118, 147). Elevated levels of PDGF-B peptide were also 
found in cultured SMC exposed to cyclic strain (193). In contrast, Malek et al. (107) 
found that shear stress significantly downregulated PDGF-B mRNA in cultured BAECs. 
In this same study, however, cyclic strain was found to have no effect on PDGF-B 
expression.
In the current study as discussed in the previous chapter, early medial and 
subsequent endothelial expression of PDGF-A mRNA was significantly upregulated after 
exposure to elevated blood flow. The aim o f this current chapter is to further analyze the
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contribution of PDGF in flow-induced vessel wall remodeling through in situ hybridization 
analysis of PDGF-B mRNA transcription.
Results
Figure 10-1 illustrates data from in situ hybridization for medial PDGF-B mRNA 
expression. An elevated baseline level o f medial PDGF-B expression is noted especially in 
the ileal artery. No significant differences were detected between control and high flow 
vessels at any time in both ileal and branch arteries. Expression o f PDGF-B in the ileal 
artery media after 7 days is elevated in both the control and high flow vessels when 
compared to I and 3 day vessels. Figure 10-2 shows data for endothelial expression of 
PDGF-B. Significant increases (+62%) are evident in the ileal artery after 7 days. No 
other significant differences were detected between control and high flow vessels. Again, 
a basal level o f endothelial PDGF-B expression is shown, especially in the ileal artery 
endothelium. Basal levels in the second-order artery are relatively low. Figure 10-3 
illustrates autoradiographs for PDGF-B mRNA expression for same animal sense and anti­
sense control and high flow vessels.
Discussion
As discussed in Chapter S, the primary flow-induced stimulus in this model was 
determined to be shear stress with possible involvement of stretch-induced wall stress in 
the ileal artery. These flow-associated stresses had no impact on medial wall expression of 
PDGF-B mRNA (Fig. 10-1), suggesting that medial wall PDGF-B is not involved in the 
flow-regulated arterial remodeling observed in this study. However, a significant 
upregulation of endothelial PDGF-B mRNA was apparent after exposure to elevated flow 
for 7 days (Fig. 10-2). This is in agreement with the findings of several other investigators
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Figure 10-1. Medial SMC PDGF-B mRNA Expression. Medial wall SMC PDGF-B 
mRNA expression for control and high flow ileal and second-order branch vessels after in 
situ hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 
10 weeks. No significant differences were detected between control and high flow 
vessels at any time. Transcript levels of both control and high flow ileal arteries were 
elevated after exposure to elevated flow for 7 days. Basal production of PDGF-B mRNA 
is noted for both the ileal and second-order arteries. Values represent mean ± SEM, and 
n = 8 for the ileal artery group and n = 6 for the second-order artery group.
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Figure 10-2. Endothelial PDGF-B mRNA Expression. Endothelial PDGF-B mRNA 
expression for control and high flow ileal and second-order branch vessels after in situ 
hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 10 
weeks. A significant increase in ileal artery PDGF-B mRNA occurred after exposure to 
flow for 7 days, while no other significant differences were detected at any time. An 
elevated basal level of PDGF expression is obvious in the ileal artery endothelium. 
Values represent mean ± SEM, and n = 8 for the ileal artery group and n = 6 for the 
second-order artery group.
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Figure 10-3. Autoradiographs for PDGF-B mRNA Expression.
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who demonstrated shear stress increased the endothelial expression of PDGF-B in 
cultured cells (64, 66, 118, 147). In comparison, these studies were generally short-term, 
and PDGF-B upregulation was transient with a subsequent reduction towards basal levels. 
In the current study, only chronic exposure to flow-associated stresses resulted in a 
significant upregulation of endothelial PDGF-B message. This result is rather counter­
intuitive considering that immediate EC replication occurred after 24 hours (Figs. 6-9, 6- 
10). The lack o f early induction o f endothelial PDGF-B after exposure to increased flow 
for 1 and 3 days suggests that perhaps the endothelium requires a prolonged time for 
sensing flow-associated stresses and may be specific for the arteries used in this 
experimental model.
Autocrine growth stimulation by PDGF has been characterized by several 
investigators (115, 154, 185). However, autocrine mitogenicity from PDGF-B does not 
seem to be involved in the current model, considering that differences were not detected 
between control and high flow vessels yet the high flow vessels experienced significant 
cellular hyperplasia and vessel wall hypertrophy. Only after 7 days of elevated flow does 
the endothelium exhibit significant PDGF-B expression (Fig. 10-2). According to 
Vlodavsky et al. (184), PDGF exerts its mitogenic action in a paracrine fashion affecting 
neighboring cells within the vessel wall. In the present study, elevated PDGF-A mRNA 
expression in the vessel media after 24 hours could reasonably act through a paracrine 
loop to induce subsequent endothelial transcription of PDGF-B chain after 7 days. 
Endothelial expression of PDGF-A chain was elevated after 3 and 7 days (Fig. 9-2), 
supporting evidence for this proposed feedback loop initially stimulated by medial PDGF- 
A mRNA.
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A basal level of medial and endothelial PDGF-B expression was evident in this 
study, consistent with findings in cultured SMCs (125, 163) and ECs (64, 65, 66). 
Majesky et al. (106) suggested this constitutive expression of PDGF may allow normal 
vessels to synthesize and respond to both basal and increased levels of PDGF in order to 
maintain a normal cellular environment.
In conclusion, results from this chapter do not implicate medial or endothelial 
PDGF-B expression in regulating the flow-induced arterial remodeling observed in this 
study. Expression of endothelial PDGF-B message became significant only after exposure 
to flow for 7 days and was not involved in the earlier SMC or EC mitogenic events. Basal 
levels of both medial and endothelial PDGF-B mRNA were detected, providing support 
for its role in maintaining vascular homeostasis.
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CHAPTER XI
NEITHER bFGF NOR TGF-01 CONTRIBUTE TO VESSEL WALL 
REMODELING FROM INCREASED BLOOD FLOW
Introduction
As discussed in the previous chapters, PDGF is a vital growth factor capable of 
mediating vasoconstriction, chemotaxis, mitogenicity, and various other homeostatic and 
pathophysiologic functions in a variety of cell types. PDGF-A mRNA expression was 
found to be stimulated by flow-associated stresses possibly contributing to flow-induced 
vessel wall remodeling under in vivo conditions. Several other growth-regulating factors 
including bFGF and TGF-Pl have been implicated in the etiology of abnormal arterial 
growth and vascular remodeling. Basic FGF has important properties that readily 
influence migration and growth of vascular cells. Since bFGF has no obvious signal 
sequence (18), its secretion is thought to occur in combination with carrier proteins, 
through interaction with ECM proteins (22, 149, 158), or through disruption of the 
plasma membrane in cell lysis during vascular injuries (30). Mechanically-injured SMCs 
were found to release biologically active bFGF into the medium that was cytosolic in 
origin and not dependent on ECM-release (30). Significant release of bFGF was found in 
rat iliac veins exposed to elevated arterial flows from bypass grafting, suggesting a role for 
bFGF in stimulating myointimal hyperplasia after bypass surgery (161). Shear stress- 
induced alterations in bFGF transcription (107) and protein release (172) have also been 
characterized in cultured ECs and SMCs. The first goal of this present chapter is to
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characterize the contribution of endothelial and smooth muscle bFGF expression in 
mediating flow-induced vessel wall remodeling under in vivo conditions.
Transforming growth factor-P 1 exerts multiple effects on the vascular environment 
which depend on various parameters such as the presence of cytokines or other growth 
factors and on the stage of cellular differentiation. Owens et al. (135) observed TGF-p 1 
to inhibit SMC hyperplasia by increasing cell cycle time while concurrently inducing 
cellular hypertrophy by increasing accumulation of cells in the G2 phase o f the cell cycle. 
Gibbons and co-workers (53, 83) found All stimulated conversion of the latent inactive 
form of TGF-P 1 to a biologically active form which induced SMC hypertrophy. Presence 
of the latent inactive form of TGF-P 1 resulted in SMC hyperplasia. TGF-P 1 is also 
capable of autocrine stimulation of its own transcription in a positive feedback loop in 
normal and transformed cultured cells (182). TGF-P 1 plays a role in stimulating synthesis 
of ECM components (71, 150). This growth factor has also been implicated in 
morphogenesis of fibroblasts, mitogenesis of osteoblasts and Schwann cells, and 
chemotaxis of fibroblasts and monocytes (reviewed in 161). Shear stress stimulated 
transcription and production of TGF-P 1 has been characterized in cultured endothelium by 
Ohno et al. (128, 129, 131). The second goal of this chapter is to characterize the 
contribution of endothelial and smooth muscle TGF-P 1 expression in mediating flow- 
induced vessel wall remodeling under in vivo conditions.
Results
In situ hybridization data for medial wall and endothelial bFGF mRNA are 
graphically illustrated in Figures 11-1 and 11-2. No significant differences were detected 
between control and high flow vessels at any time in either the media or the endothelium.

























Figure 11-1. Medial SMC bFGF mRNA Expression. Medial wall SMC bFGF mRNA 
expression for control and high flow ileal and second-order branch vessels after in situ 
hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 10 
weeks. No significant differences were detected between control and high flow vessels at 
any time point. Medial SMC basal levels of expression were negligible for both ileal artery 
and second-order branch. Values represent mean ± SEM, and n = 8 for the ileal artery 
group and n = 6 for the second-order artery group.
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Figure 11-2. Endothelial bFGF mRNA Expression. Endothelial bFGF mRNA 
expression for control and high flow ileal and second-order branch vessels after in situ 
hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 10 
weeks. Endothelial bFGF expression was quite minimal, with no significant differences 
detected between control and high flow vessels. Values represent mean ± SEM, and n = 
8 for the ileal artery group and n = 6 for the second-order artery group.
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Figure 11-3. Autoradiographs for bFGF mRNA Expression.
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Medial and endothelial expression of bFGF in the ileal artery and second-order branch 
were quite low. Figure 11-3 contains autoradiographs for bFGF mRNA expression for 
same animal sense and anti-sense control and high flow vessels. Figures 11-4 and I l-S 
show medial and endothelial expression of TGF-P 1, respectively. Similarly, most time 
points indicate low expression of TGF-P 1 expression; however, ileal artery medial 
expression is significantly increased for high flow vessels compared to controls after 7 
days (Fig. 11-4). An interesting but statistically insignificant upregulation of TGF-P 1 is 
observed in both control and high flow second-order arteries after 24 hours in the media 
and endothelium. Figure 11-6 shows autoradiographs o f TGF-P 1 expression for same 
animal sense and anti-sense control and high flow vessels.
Discussion
Results from in situ hybridization reveal low basal and flow-induced levels of 
expression of bFGF in vivo (Figs. 11-1, 11-2). Low levels of basal expression of bFGF 
have been documented elsewhere (18, 75); however, shear stress was found to upregulate 
bFGF mRNA and protein release in cultured BAECs (107, 172). Basic FGF peptides are 
predominantly associated with the ECM, and release can be stimulated by proteolytic 
enzymes (22). According to Baird and Ling (18), a major determinant of bFGF-induced 
neovascularization is not expression of the factor but the presence of these extracellular 
enzymes. In the current study as discussed in Chapter 7, flow-associated stresses 
stimulated increased extracellular connective tissue. Accordingly, flow could also 
stimulate increased production of extracellular enzymes, although no studies have focused 
on this to date. In the current study, bFGF expression was insignificant in mediating flow- 
induced remodeling in small arteries. In addition, cells generally increase transcription of































Figure 11-4. Medial SMC TGF-p 1 mRNA Expression. Medial wall SMC TGF-p 1 
mRNA expression for control and high flow ileal and second-order branch vessels after in 
situ hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 
10 weeks. Ileal artery basal expression was not observed, and a significant increase in high 
flow occurred after exposure to flow for 7 days. No other differences were detected 
between control and high flow vessels at any time. Interestingly, both control and high 
flow second-order arteries had elevated levels of TGF-P 1 expression after 24 hours, and 
both decreased by 3 and 7 days. Values represent mean ± SEM, and n = 7 for the ileal 
artery group and n = 6 for the second-order artery group.
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Figure 11-5. Endothelial TGF-P 1 mRNA Expression. Endothelial TGF-P I mRNA 
expression for control and high flow ileal and second-order branch vessels after in situ 
hybridization with 35S-CTP riboprobe and development of silver grain emulsion after 10 
weeks. No significant differences were detected between control and high flow vessels at 
any time. Overall expression in the ileal artery was quite low. Both control and high flow 
second-order arteries experienced elevated levels of TGF-P 1 expression after 24 hours, 
and both decreased by 3 and 7 days. Values represent mean ± SEM, and n = for the ileal 
artery group and n = for the second-order artery group.
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Figure 11-6. Autoradiographs for TGF-P 1 mRNA Expression.
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various growth factors when under culture conditions when compared to the in vivo state 
(18), so direct extrapolation of in vitro to in vivo results requires prudence.
The influence of TGF-P 1 in mediating flow-induced vessel wall growth in the 
current model was negligible. Basal levels of TGF-P 1 expression were low in both ileal 
and second-order arteries, although the smaller branch experienced increased expression 
after 24 hours in both control and high flow vessels. The ileal artery experiences a 
significant increase in medial TGF-P 1 expression after exposure to flow for 7 days. Since 
TGF-P 1 has been shown to be upregulated with shear stress (128, 129, 131), and 
considering that TGF-P 1 can auto-stimulate its own message (182), perhaps after 7 days 
significant increases in self-stimulated expression are finally achieved (Fig. 11-4). The ileal 
artery at this time point is undergoing significant DNA replication and cellular hyperplasia 
(Figs. 6-6, 6-8, 6-9), which would correlate with the presence of a latent inactive form of 
TGF-P 1 peptide. Also, TGF-P I has been found to stimulate syntheses of extracellular 
fibronectin and collagen (71, 150), as well as their incorporation into the ECM (71). In 
the current model, however, TGF-P 1 does not seem to be involved in increased synthesis 
of the extracellular connective tissue observed (Fig. 7-1). Generally speaking, the role of 
TGF-P 1 in mediating flow-induced medial wall hypertrophy observed in this in vivo model 
is minimal.
In conclusion, results from this chapter imply that bFGF and TGF-P I were not 
directly involved in the flow-mediated vessel wall remodeling observed under in vivo 
conditions. Elevated medial wall TGF-P 1 expression after 7 days suggests the possibility 
of autocrine stimulation of TGF-P 1 transcription in flow-exposed vessels.




The investigation discussed in these chapters details a unique experimental model 
that allows molecular and histologic analyses of arterial wall remodeling in response to 
altered hemodynamic parameters under in vivo conditions. The primary stimulus in this 
model was flow-induced shear stress with possible contribution from stretch-induced wall 
stress in the ileal artery. Flow-induced luminal expansion and medial wall hypertrophy 
occurred in deal and second-order branching arteries in a time-dependent fashion over a 7 
day period. These structural adaptations involved early and dramatic EC hyperplasia after 
24 hours with subsequent medial SMC DNA replication and hyperplasia after 3 days. 
These medial wall changes also involved a concomitant increase in extracellular connective 
tissue.
Nitric oxide is suggested as a possible signaling factor in these flow-mediated 
arterial alterations. Early medial and subsequent endothelial PDGF-A mRNA expression 
possibly contributes to SMC and EC replication and vessel wall remodeling. Expression 
of medial and endothelial PDGF-B, bFGF, and TGF-P 1 was not significantly affected by 
flow-associated stresses in this model, and their roles in mediating the flow-induced 
alterations observed are believed to be minimal.
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